Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyBiologicalProcess	cell morphogenesis involved in neuron differentiation	BOC ARHGAP32 NPTX1 CDHR1 CD2AP APC DSCAML1 PTK2 TIAM2 CDKL5 NEO1 NFATC4 PTPRS NFIB GLI3 ARC AFDN RERE PLS1	3.80e-07	748	134	19	GO:0048667
GeneOntologyBiologicalProcess	animal organ morphogenesis	FLI1 ASXL1 ERBB4 TCF7 SDK2 FOXN4 APC EXT2 ZFPM1 SOX8 DSCAML1 PTK2 RYR2 HOXB3 PAX8 NFIB FZD5 GLI1 GLI3 TLE3 PKD1 AFDN PLS1 COL1A1 WDR48	5.71e-07	1269	134	25	GO:0009887
GeneOntologyBiologicalProcess	cell morphogenesis	BOC ASXL1 ARHGAP32 NPTX1 CDHR1 CD2AP APC ZFPM1 DSCAML1 THOC5 PTK2 TIAM2 CDKL5 NEO1 NFATC4 PTPRS NFIB GLI3 ARC AFDN RERE PLEC PLS1 BRWD1	6.98e-07	1194	134	24	GO:0000902
GeneOntologyBiologicalProcess	multicellular organismal-level homeostasis	SLC46A2 ASXL1 ERBB4 ERCC6 SGIP1 ACACA CDHR1 CD2AP APC EXT2 ZFPM1 KDM6B KMT2E ADAR NEO1 NFIB ABCC8 TLE3 AFDN MUC5AC LILRB5 WDR48	9.84e-07	1043	134	22	GO:0048871
GeneOntologyBiologicalProcess	circulatory system development	FOXJ2 ASXL1 ERBB4 THSD7A SASH1 FOXN4 PKD1L1 APC ZFPM1 KDM6B PTK2 RYR2 EOMES NFATC2 NFATC4 EGR3 PAX8 FZD5 GLI1 GLI3 ABCC8 PKD1 PLEC VAV2 DNMT1 COL1A1	1.73e-06	1442	134	26	GO:0072359
GeneOntologyBiologicalProcess	embryonic organ development	TCF7 FOXN4 ZFPM1 DSCAML1 THOC5 RYR2 EOMES HOXB3 PAX8 FZD5 GLI1 GLI3 PKD1 PLS1 WDR48	3.81e-06	561	134	15	GO:0048568
GeneOntologyBiologicalProcess	neuron projection morphogenesis	BOC ARHGAP32 NPTX1 CD2AP APC DSCAML1 PTK2 TIAM2 CDKL5 NEO1 NFATC4 PTPRS NFIB GLI3 ARC AFDN RERE	1.79e-05	802	134	17	GO:0048812
GeneOntologyBiologicalProcess	plasma membrane bounded cell projection morphogenesis	BOC ARHGAP32 NPTX1 CD2AP APC DSCAML1 PTK2 TIAM2 CDKL5 NEO1 NFATC4 PTPRS NFIB GLI3 ARC AFDN RERE	2.34e-05	819	134	17	GO:0120039
GeneOntologyBiologicalProcess	cell projection morphogenesis	BOC ARHGAP32 NPTX1 CD2AP APC DSCAML1 PTK2 TIAM2 CDKL5 NEO1 NFATC4 PTPRS NFIB GLI3 ARC AFDN RERE	2.60e-05	826	134	17	GO:0048858
GeneOntologyBiologicalProcess	anatomical structure formation involved in morphogenesis	FOXJ2 SDK2 THSD7A SASH1 FOXN4 EXT2 ZFPM1 SOX8 KDM6B PTK2 EOMES NEO1 NFATC2 NFATC4 EGR3 PAX8 NFIB FZD5 GLI3 ABCC8 PKD1 PLEC VAV2 COL1A1	2.80e-05	1483	134	24	GO:0048646
GeneOntologyBiologicalProcess	positive regulation of transcription by RNA polymerase II	FOXJ2 FLI1 ASXL1 ERCC6 FOXN4 ZNF395 ZFPM1 SOX8 KDM6B HNF4G EOMES HOXB3 NFATC2 NFATC4 EGR3 PAX8 NFIB FZD5 GLI1 GLI3 ZMIZ2 PKD1 CREB3L3	2.99e-05	1390	134	23	GO:0045944
GeneOntologyBiologicalProcess	heart development	ASXL1 ERBB4 FOXN4 PKD1L1 APC ZFPM1 KDM6B PTK2 RYR2 EOMES NFATC4 PAX8 GLI1 GLI3 PKD1 PLEC	3.33e-05	757	134	16	GO:0007507
GeneOntologyBiologicalProcess	negative regulation of developmental process	FOXJ2 SFMBT1 ASXL1 KREMEN1 APC ZFPM1 SOX8 THOC5 PTK2 NEO1 NFATC2 NFATC4 PAX8 PTPRS NFIB GLI3 ABCC8 DISP3 CDK5RAP2 LILRB5 DNMT1	3.93e-05	1220	134	21	GO:0051093
GeneOntologyBiologicalProcess	canonical Wnt signaling pathway involved in negative regulation of apoptotic process	TCF7 APC	4.19e-05	2	134	2	GO:0044336
GeneOntologyBiologicalProcess	epithelial cell differentiation	FOXJ2 ASXL1 ERBB4 CD2AP APC SOX8 LIPK KDM6B PAX8 PTPRS NFIB FZD5 GLI1 AFDN PLAUR PLEC PLS1	4.98e-05	870	134	17	GO:0030855
GeneOntologyBiologicalProcess	epithelium development	FOXJ2 ASXL1 ERBB4 TCF7 FOXN4 CD2AP APC SOX8 LIPK KDM6B RYR2 NFATC4 PAX8 PTPRS NFIB FZD5 GLI1 GLI3 PKD1 AFDN PLAUR PLEC PLS1	7.01e-05	1469	134	23	GO:0060429
GeneOntologyBiologicalProcess	gland development	SLC46A2 ASXL1 ERBB4 CD2AP APC CPT1A HOXB3 PAX8 NFIB GLI1 GLI3 PKD1 PLAUR	7.21e-05	558	134	13	GO:0048732
GeneOntologyBiologicalProcess	cell fate commitment	ERBB4 FOXN4 APC ZFPM1 SOX8 KDM6B DSCAML1 EOMES NFIB GLI3	7.40e-05	338	134	10	GO:0045165
GeneOntologyBiologicalProcess	axon development	BOC ARHGAP32 NPTX1 KREMEN1 CD2AP APC DSCAML1 PTK2 TIAM2 CDKL5 NEO1 PTPRS NFIB GLI3	7.65e-05	642	134	14	GO:0061564
GeneOntologyBiologicalProcess	axonogenesis	BOC ARHGAP32 NPTX1 CD2AP APC DSCAML1 PTK2 TIAM2 CDKL5 NEO1 PTPRS NFIB GLI3	8.32e-05	566	134	13	GO:0007409
GeneOntologyBiologicalProcess	embryonic organ morphogenesis	TCF7 FOXN4 DSCAML1 RYR2 HOXB3 PAX8 FZD5 GLI1 GLI3 PLS1	1.01e-04	351	134	10	GO:0048562
GeneOntologyBiologicalProcess	synapse organization	ERBB4 NPTX1 SDK2 CD2AP PTK2 CDKL5 NFATC4 PTPRS FZD5 ARHGEF9 ARC AFDN BSN SEZ6L	1.51e-04	685	134	14	GO:0050808
GeneOntologyBiologicalProcess	pattern specification process	ERBB4 FOXN4 PKD1L1 APC DSCAML1 EOMES HOXB3 PAX8 FZD5 GLI1 GLI3 ARC	1.68e-04	526	134	12	GO:0007389
GeneOntologyBiologicalProcess	negative regulation of axon regeneration	KREMEN1 NEO1 PTPRS	1.71e-04	17	134	3	GO:0048681
GeneOntologyBiologicalProcess	synapse assembly	ERBB4 NPTX1 SDK2 PTK2 PTPRS FZD5 ARHGEF9 AFDN BSN	1.88e-04	308	134	9	GO:0007416
GeneOntologyBiologicalProcess	cell junction organization	ERBB4 NPTX1 SDK2 CD2AP APC PTK2 CDKL5 NFATC4 PTPRS FZD5 ABCC8 ARHGEF9 ARC AFDN PLEC BSN SEZ6L	1.95e-04	974	134	17	GO:0034330
GeneOntologyBiologicalProcess	embryonic morphogenesis	TCF7 FOXN4 EXT2 SOX8 KDM6B DSCAML1 RYR2 EOMES HOXB3 PAX8 FZD5 GLI1 GLI3 PLS1	2.28e-04	713	134	14	GO:0048598
GeneOntologyBiologicalProcess	neuron projection development	BOC ARHGAP32 NPTX1 ERCC6 KREMEN1 CD2AP APC DSCAML1 PTK2 TIAM2 CDKL5 NEO1 NFATC4 PTPRS NFIB GLI3 ARC AFDN RERE PLS1	2.38e-04	1285	134	20	GO:0031175
GeneOntologyBiologicalProcess	metanephric nephron tubule formation	SOX8 PAX8	2.49e-04	4	134	2	GO:0072289
GeneOntologyBiologicalProcess	regulation of cell development	SLC46A2 ARHGAP32 TCF7 APC ZFPM1 SOX8 THOC5 PTK2 TIAM2 CDKL5 HOXB3 NFATC4 EGR3 PTPRS GLI3 ABCC8 AFDN LILRB5	2.61e-04	1095	134	18	GO:0060284
GeneOntologyBiologicalProcess	developmental growth	ARHGAP32 ERBB4 ERCC6 SGIP1 ATN1 CD2AP APC PTK2 CDKL5 PTPRS GLI1 GLI3 AFDN PLEC PLS1 WDR48	2.84e-04	911	134	16	GO:0048589
GeneOntologyBiologicalProcess	regionalization	FOXN4 PKD1L1 APC DSCAML1 EOMES HOXB3 PAX8 FZD5 GLI1 GLI3 ARC	2.93e-04	478	134	11	GO:0003002
GeneOntologyBiologicalProcess	tube morphogenesis	FOXJ2 TCF7 THSD7A SASH1 FOXN4 SOX8 PTK2 RYR2 NFATC4 EGR3 PAX8 NFIB FZD5 GLI1 GLI3 ABCC8 PKD1 VAV2	3.61e-04	1125	134	18	GO:0035239
GeneOntologyBiologicalProcess	tight junction organization	APC FZD5 ABCC8 AFDN PLEC	3.71e-04	94	134	5	GO:0120193
GeneOntologyBiologicalProcess	negative regulation of neuron projection regeneration	KREMEN1 NEO1 PTPRS	3.77e-04	22	134	3	GO:0070571
GeneOntologyBiologicalProcess	tissue morphogenesis	ERBB4 FOXN4 APC EXT2 ZFPM1 SOX8 KDM6B RYR2 EOMES NFATC4 PAX8 FZD5 GLI3 PKD1	3.80e-04	750	134	14	GO:0048729
GeneOntologyBiologicalProcess	connective tissue development	CD2AP EXT2 SOX8 HOXB3 NFATC2 NFIB GLI3 PKD1 COL1A1	4.13e-04	343	134	9	GO:0061448
GeneOntologyBiologicalProcess	lncRNA transcription	NFATC2 CELF3	4.14e-04	5	134	2	GO:0140742
GeneOntologyBiologicalProcess	regulation of developmental growth	ARHGAP32 ERBB4 SGIP1 APC PTK2 CDKL5 PTPRS GLI1 AFDN PLS1	4.34e-04	421	134	10	GO:0048638
GeneOntologyBiologicalProcess	neuron development	BOC ARHGAP32 NPTX1 ERCC6 KREMEN1 CDHR1 CD2AP APC DSCAML1 PTK2 TIAM2 CDKL5 NEO1 NFATC4 PTPRS NFIB GLI3 ARC AFDN RERE PLS1	4.86e-04	1463	134	21	GO:0048666
GeneOntologyBiologicalProcess	cell differentiation involved in kidney development	ASXL1 CD2AP PAX8 GLI3	5.15e-04	57	134	4	GO:0061005
GeneOntologyBiologicalProcess	regulation of neurogenesis	ARHGAP32 SOX8 PTK2 TIAM2 CDKL5 HOXB3 NFATC4 PTPRS GLI3 ABCC8 AFDN	5.49e-04	515	134	11	GO:0050767
GeneOntologyBiologicalProcess	negative regulation of cell differentiation	FOXJ2 ASXL1 ZFPM1 SOX8 THOC5 PTK2 NFATC2 NFATC4 PTPRS GLI3 ABCC8 DISP3 CDK5RAP2 LILRB5 DNMT1	5.71e-04	875	134	15	GO:0045596
GeneOntologyBiologicalProcess	metanephric tubule formation	SOX8 PAX8	6.18e-04	6	134	2	GO:0072174
GeneOntologyBiologicalProcess	dorsal/ventral pattern formation	FOXN4 APC DSCAML1 GLI1 GLI3	6.72e-04	107	134	5	GO:0009953
GeneOntologyBiologicalProcess	definitive hemopoiesis	ZFPM1 ADAR HOXB3	7.00e-04	27	134	3	GO:0060216
GeneOntologyBiologicalProcess	tube development	FOXJ2 ASXL1 TCF7 THSD7A SASH1 FOXN4 SOX8 PTK2 RYR2 NFATC4 EGR3 PAX8 NFIB FZD5 GLI1 GLI3 ABCC8 PKD1 VAV2 WDR48	7.25e-04	1402	134	20	GO:0035295
GeneOntologyBiologicalProcess	central nervous system development	ERBB4 NPTX1 ATN1 FOXN4 SOX8 KDM6B DSCAML1 PTK2 EOMES HOXB3 PTPRS NFIB GLI1 GLI3 CDK5RAP2 AFDN RERE SEZ6L	7.49e-04	1197	134	18	GO:0007417
GeneOntologyCellularComponent	nuclear body	FLI1 TCF7 ERCC6 C11orf54 ANKS1B ZNF395 KMT2E ADAR PTK2 NFATC4 GLI3 CELF3 YLPM1 TIMM50 AFDN RERE REXO1L1P	8.85e-05	903	137	17	GO:0016604
GeneOntologyCellularComponent	postsynaptic density	ARHGAP32 ERBB4 ANKS1B RPS6KC1 CDKL5 NEO1 PTPRS ARHGEF9 ARC AFDN BSN	1.93e-04	451	137	11	GO:0014069
GeneOntologyCellularComponent	GLI-SUFU complex	GLI1 GLI3	2.54e-04	4	137	2	GO:1990788
GeneOntologyCellularComponent	asymmetric synapse	ARHGAP32 ERBB4 ANKS1B RPS6KC1 CDKL5 NEO1 PTPRS ARHGEF9 ARC AFDN BSN	3.12e-04	477	137	11	GO:0032279
GeneOntologyCellularComponent	cytoplasmic vesicle membrane	SLC46A2 ARHGAP32 TEPSIN SGIP1 SEC24A DOK3 APC DTX3L SNX33 ASB14 PTPRS FZD5 ABCC8 PKD1 STARD3 DISP3 ARC PLAUR BSN CA4	3.37e-04	1307	137	20	GO:0030659
GeneOntologyCellularComponent	vesicle membrane	SLC46A2 ARHGAP32 TEPSIN SGIP1 SEC24A DOK3 APC DTX3L SNX33 ASB14 PTPRS FZD5 ABCC8 PKD1 STARD3 DISP3 ARC PLAUR BSN CA4	4.02e-04	1325	137	20	GO:0012506
GeneOntologyCellularComponent	AP-4 adaptor complex	TEPSIN AP4E1	4.21e-04	5	137	2	GO:0030124
GeneOntologyCellularComponent	postsynaptic specialization	ARHGAP32 ERBB4 ANKS1B RPS6KC1 CDKL5 NEO1 PTPRS ARHGEF9 ARC AFDN BSN	4.87e-04	503	137	11	GO:0099572
GeneOntologyCellularComponent	neuron to neuron synapse	ARHGAP32 ERBB4 ANKS1B RPS6KC1 CDKL5 NEO1 PTPRS ARHGEF9 ARC AFDN BSN	6.73e-04	523	137	11	GO:0098984
GeneOntologyCellularComponent	somatodendritic compartment	BOC ARHGAP32 ERBB4 KREMEN1 CD2AP ANKS1B APC PTK2 TIAM2 CDKL5 NEO1 PTPRS FZD5 ARC AFDN PLEC BSN SEZ6L	1.12e-03	1228	137	18	GO:0036477
GeneOntologyCellularComponent	growth cone	BOC CD2AP APC TIAM2 CDKL5 NEO1 PTPRS	1.18e-03	245	137	7	GO:0030426
GeneOntologyCellularComponent	site of polarized growth	BOC CD2AP APC TIAM2 CDKL5 NEO1 PTPRS	1.42e-03	253	137	7	GO:0030427
GeneOntologyCellularComponent	chromatin	FOXJ2 FLI1 TCF7 ERCC6 FOXN4 ZFPM1 SOX8 KMT2E HNF4G EOMES HOXB3 NFATC2 NFATC4 EGR3 PAX8 NFIB ZMIZ2 FOXI2 CREB3L3 DNMT1	1.58e-03	1480	137	20	GO:0000785
Domain	Atrophin-like	ATN1 RERE	5.34e-05	2	137	2	IPR002951
Domain	Atrophin-1	ATN1 RERE	5.34e-05	2	137	2	PF03154
Pathway	REACTOME_GLI_PROTEINS_BIND_PROMOTERS_OF_HH_RESPONSIVE_GENES_TO_PROMOTE_TRANSCRIPTION	BOC GLI1 GLI3	1.50e-05	7	108	3	M27501
Pathway	KEGG_BASAL_CELL_CARCINOMA	TCF7 APC FZD5 GLI1 GLI3	6.17e-05	55	108	5	M17807
Pubmed	A census of human transcription factors: function, expression and evolution.	FOXJ2 FLI1 TCF7 FOXN4 ZNF395 ZFPM1 SOX8 HNF4G ZC3H3 EOMES HOXB3 NFATC2 NFATC4 EGR3 PAX8 NFIB GLI1 GLI3 FOXI2 RERE CREB3L3	9.91e-11	908	139	21	19274049
Pubmed	Proximity-dependent biotin identification (BioID) reveals a dynamic LSD1-CoREST interactome during embryonic stem cell differentiation.	SFMBT1 ACACA ERP44 CD2AP APC C15orf39 SOX8 FAM193A TLE3 ZMIZ2 RERE PLEC	1.31e-07	418	139	12	34709266
Pubmed	Proteome-scale mapping of binding sites in the unstructured regions of the human proteome.	ARHGAP32 ERBB4 ATN1 BCAR1 KMT2E PTK2 FAM193A NFATC4 ZMIZ2 YLPM1 PLEC BSN	1.78e-07	430	139	12	35044719
Pubmed	Atrophin 2 recruits histone deacetylase and is required for the function of multiple signaling centers during mouse embryogenesis.	ATN1 GLI1 GLI3 RERE	7.16e-07	18	139	4	14645126
Pubmed	Pro-prion, as a membrane adaptor protein for E3 ligase c-Cbl, facilitates the ubiquitination of IGF-1R, promoting melanoma metastasis.	ERP44 CD2AP FASTKD1 WIPF3 APC DTX3L SNX33 PDCD7 DSCAML1 THOC5 NFIB ZMIZ2 CDK5RAP2 WDR48	7.57e-07	689	139	14	36543142
Pubmed	APC sets the Wnt tone necessary for cerebral cortical progenitor development.	APC EOMES GLI1 GLI3	9.04e-07	19	139	4	28916710
Pubmed	Human transcription factor protein interaction networks.	FLI1 ASXL1 ARHGAP32 TCF7 ATN1 SEC24A C15orf39 PCF11 NFATC4 PAX8 NFIB GLI3 TLE3 ZMIZ2 SLC25A13 YLPM1 TIMM50 RERE R3HDM1 WDR48	1.11e-06	1429	139	20	35140242
Pubmed	Hedgehog signaling controls mesenchymal growth in the developing mammalian digestive tract.	FLI1 GLI1 MUC5AC COL1A1	1.69e-06	22	139	4	20430747
Pubmed	Scleraxis and NFATc regulate the expression of the pro-alpha1(I) collagen gene in tendon fibroblasts.	NFATC2 NFATC4 COL1A1	2.16e-06	7	139	3	17430895
Pubmed	Spatiotemporal expression of sonic hedgehog signalling molecules in the embryonic mesencephalic dopaminergic neurons.	BOC GLI1 GLI3	3.45e-06	8	139	3	34767969
Pubmed	Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics.	NPTX1 THSD7A APC SNX33 PTK2 RPS6KC1 FAM193A NAV3 BOP1 DNMT1 COL1A1	3.58e-06	475	139	11	31040226
Pubmed	Loss of Suppressor of Fused in Mid-Corticogenesis Leads to the Expansion of Intermediate Progenitors.	EOMES GLI1 GLI3	5.16e-06	9	139	3	28781964
Pubmed	Inhibition of Poly(ADP-Ribose) Polymerase-1 Protects Chronic Alcoholic Liver Injury.	ACACA CPT1A COL1A1	5.16e-06	9	139	3	27746183
Pubmed	Modification of the composition of polycystin-1 multiprotein complexes by calcium and tyrosine phosphorylation.	BCAR1 PTK2 PKD1	7.34e-06	10	139	3	11113628
Pubmed	Neogenin regulates Sonic Hedgehog pathway activity during digit patterning.	NEO1 GLI1 GLI3	7.34e-06	10	139	3	22275192
Pubmed	An inducible CRISPR/Cas9 screen identifies DTX2 as a transcriptional regulator of human telomerase.	ARHGAP32 ACACA C15orf39 PCF11 NFIB YLPM1 R3HDM1	8.50e-06	180	139	7	35198878
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	ARHGAP32 ERBB4 ACACA SASH1 SEC24A CD2AP APC BCAR1 ARHGEF17 TIMM50 AFDN PLEC R3HDM1 DNMT1	9.83e-06	861	139	14	36931259
Pubmed	Role of Indian hedgehog signaling in palatal osteogenesis.	GLI1 GLI3 COL1A1	1.01e-05	11	139	3	21364421
Pubmed	Gli1 protein participates in Hedgehog-mediated specification of osteoblast lineage during endochondral ossification.	GLI1 GLI3 COL1A1	1.01e-05	11	139	3	22493482
Pubmed	RNF43 inhibits WNT5A-driven signaling and suppresses melanoma invasion and resistance to the targeted therapy.	ARHGAP32 SEC24A APC AP4E1 FAM193A MEIOC GLI3 R3HDM1	1.15e-05	263	139	8	34702444
Pubmed	Impact of cytosine methylation on DNA binding specificities of human transcription factors.	FOXJ2 FLI1 TCF7 SOX8 EOMES NFATC2 NFATC4 EGR3 PAX8 NFIB GLI3	1.28e-05	544	139	11	28473536
Pubmed	Genomic analysis of mouse retinal development.	FOXN4 CDHR1 FASTKD1 APC BCAR1 CPT1A ADAR PTK2 PTPRS FZD5 CELF3 PKD1 NAV3 PLEC BSN	1.30e-05	1006	139	15	15226823
Pubmed	Dynamic patterning at the pylorus: formation of an epithelial intestine-stomach boundary in late fetal life.	HNF4G GLI1 CREB3L3	1.34e-05	12	139	3	19877272
Pubmed	Grit, a GTPase-activating protein for the Rho family, regulates neurite extension through association with the TrkA receptor and N-Shc and CrkL/Crk adapter molecules.	ARHGAP32 BCAR1 SHC2	1.34e-05	12	139	3	12446789
Pubmed	Impaired OTUD7A-dependent Ankyrin regulation mediates neuronal dysfunction in mouse and human models of the 15q13.3 microdeletion syndrome.	ERBB4 SDK2 FASTKD1 ANKS1B CDKL5 ARC AFDN	1.53e-05	197	139	7	36604605
Pubmed	Defining the proximal interaction networks of Arf GTPases reveals a mechanism for the regulation of PLD1 and PI4KB.	SFMBT1 ACACA SEC24A APC RYR2 PCF11 AP4E1 CDKL5 NEO1 GLI3 CDK5RAP2 AFDN DNMT1	1.54e-05	777	139	13	35844135
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	ANKS1B APC KDM6B PDCD7 DSCAML1 PTK2 YLPM1 PKD1 NAV3 AFDN PLAUR PLEC R3HDM1 SEZ6L DNMT1 BRWD1 ZNF662	1.57e-05	1285	139	17	35914814
Pubmed	Suppression of intestinal neoplasia by DNA hypomethylation.	APC DNMT1	1.59e-05	2	139	2	7537636
Pubmed	Carvedilol and its new analogs suppress arrhythmogenic store overload-induced Ca2+ release.	RYR2 PLAUR	1.59e-05	2	139	2	21743453
Pubmed	Synergy between tumor suppressor APC and the beta-catenin-Tcf4 target Tcf1.	TCF7 APC	1.59e-05	2	139	2	10489374
Pubmed	Invasion of host cells by Salmonella typhimurium requires focal adhesion kinase and p130Cas.	BCAR1 PTK2	1.59e-05	2	139	2	16914515
Pubmed	Protein phosphatase 2A and rapamycin regulate the nuclear localization and activity of the transcription factor GLI3.	GLI1 GLI3	1.59e-05	2	139	2	18559511
Pubmed	Tyrosine dephosphorylation, but not phosphorylation, of p130Cas is dependent on integrin alpha IIb beta 3-mediated aggregation in platelets: implication of p130Cas involvement in pathways unrelated to cytoskeletal reorganization.	BCAR1 PTK2	1.59e-05	2	139	2	10801330
Pubmed	Complete genetic suppression of polyp formation and reduction of CpG-island hypermethylation in Apc(Min/+) Dnmt1-hypomorphic Mice.	APC DNMT1	1.59e-05	2	139	2	11888894
Pubmed	Molecular cloning and expression pattern of a Cubitus interruptus homologue from the mulberry silkworm Bombyx mori.	GLI1 GLI3	1.59e-05	2	139	2	12351188
Pubmed	Protein binding of a DRPLA family through arginine-glutamic acid dipeptide repeats is enhanced by extended polyglutamine.	ATN1 RERE	1.59e-05	2	139	2	10814707
Pubmed	A three-part signal governs differential processing of Gli1 and Gli3 proteins by the proteasome.	GLI1 GLI3	1.59e-05	2	139	2	21921029
Pubmed	Suppression of uPAR retards radiation-induced invasion and migration mediated by integrin β1/FAK signaling in medulloblastoma.	PTK2 PLAUR	1.59e-05	2	139	2	20886051
Pubmed	Ciprofloxacin has antifibrotic effects in scleroderma fibroblasts via downregulation of Dnmt1 and upregulation of Fli1.	FLI1 DNMT1	1.59e-05	2	139	2	23041765
Pubmed	A 77-kDa protein associates with pp125FAK in mast cells and becomes tyrosine-phosphorylated by high affinity IgE receptor aggregation.	APC PTK2	1.59e-05	2	139	2	7744883
Pubmed	Palmar and plantar pads and flexion creases of genetic polydactyly mice (Pdn).	GLI1 GLI3	1.59e-05	2	139	2	9918099
Pubmed	Tumour cell expression of C4.4A, a structural homologue of the urokinase receptor, correlates with poor prognosis in non-small cell lung cancer.	LYPD3 PLAUR	1.59e-05	2	139	2	17706320
Pubmed	Imatinib and Nilotinib increase glioblastoma cell invasion via Abl-independent stimulation of p130Cas and FAK signalling.	BCAR1 PTK2	1.59e-05	2	139	2	27293031
Pubmed	Gli3 is a Key Factor in the Schwann Cells from Both Intact and Injured Peripheral Nerves.	GLI1 GLI3	1.59e-05	2	139	2	32114096
Pubmed	Hedgehog-regulated processing of Gli3 produces an anterior/posterior repressor gradient in the developing vertebrate limb.	GLI1 GLI3	1.59e-05	2	139	2	10693759
Pubmed	Suppressive effect of global DNA hypomethylation on gastric carcinogenesis.	APC DNMT1	1.59e-05	2	139	2	20622006
Pubmed	The RNA-editing enzyme ADAR promotes lung adenocarcinoma migration and invasion by stabilizing FAK.	ADAR PTK2	1.59e-05	2	139	2	28928239
Pubmed	Enhanced mitophagy driven by ADAR1-GLI1 editing supports the self-renewal of cancer stem cells in HCC.	ADAR GLI1	1.59e-05	2	139	2	36683360
Pubmed	Parallel microarray profiling identifies ErbB4 as a determinant of cyst growth in ADPKD and a prognostic biomarker for disease progression.	ERBB4 PKD1	1.59e-05	2	139	2	28077374
Pubmed	gli, a zinc finger transcription factor and oncogene, is expressed during normal mouse development.	GLI1 GLI3	1.59e-05	2	139	2	8364225
Pubmed	Role of transcription factor NFAT in glucose and insulin homeostasis.	NFATC2 NFATC4	1.59e-05	2	139	2	16908540
Pubmed	Renal tubule Cpt1a overexpression protects from kidney fibrosis by restoring mitochondrial homeostasis.	CPT1A COL1A1	1.59e-05	2	139	2	33465052
Pubmed	Reducing DNA methylation suppresses colon carcinogenesis by inducing tumor cell differentiation.	APC DNMT1	1.59e-05	2	139	2	25939752
Pubmed	Attenuated Late-Phase Arc Transcription in the Dentate Gyrus of Mice Lacking Egr3.	EGR3 ARC	1.59e-05	2	139	2	28589041
Pubmed	Impact of Dnmt1 deficiency, with and without low folate diets, on tumor numbers and DNA methylation in Min mice.	APC DNMT1	1.59e-05	2	139	2	12538347
Pubmed	Human DNA methyltransferase gene DNMT1 is regulated by the APC pathway.	APC DNMT1	1.59e-05	2	139	2	12538344
Pubmed	Inactivation of Apc perturbs mammary development, but only directly results in acanthoma in the context of Tcf-1 deficiency.	TCF7 APC	1.59e-05	2	139	2	12226748
Pubmed	Expression of the GLI family genes is associated with tumor progression in advanced lung adenocarcinoma.	GLI1 GLI3	1.59e-05	2	139	2	25103784
Pubmed	Tyrosine Phosphorylation of Focal Adhesion Anchoring Proteins Enhances Human Pancreatic Cancer Cell Invasion.	BCAR1 PTK2	1.59e-05	2	139	2	27400161
Pubmed	Association of SNPs in EGR3 and ARC with Schizophrenia Supports a Biological Pathway for Schizophrenia Risk.	EGR3 ARC	1.59e-05	2	139	2	26474411
Pubmed	Opposing effects of DNA hypomethylation on intestinal and liver carcinogenesis.	APC DNMT1	1.59e-05	2	139	2	16174748
Pubmed	A p130Cas tyrosine phosphorylated substrate domain decoy disrupts v-crk signaling.	BCAR1 PTK2	1.59e-05	2	139	2	12119061
Pubmed	Cyclin-dependent kinase-like 5 binds and phosphorylates DNA methyltransferase 1.	CDKL5 DNMT1	1.59e-05	2	139	2	18977197
Pubmed	Expression of MLN64 influences cellular matrix adhesion of breast cancer cells, the role for focal adhesion kinase.	PTK2 STARD3	1.59e-05	2	139	2	20198306
Pubmed	Urinary-type plasminogen activator receptor (uPAR) modulates oral cancer cell behavior with alteration in p130cas.	BCAR1 PLAUR	1.59e-05	2	139	2	21630091
Pubmed	Fluoroaluminate stimulates phosphorylation of p130 Cas and Fak and increases attachment and spreading of preosteoblastic MC3T3-E1 cells.	BCAR1 PTK2	1.59e-05	2	139	2	11792571
Pubmed	Butylated hydroxyanisole and its metabolite tert-butylhydroquinone differentially regulate mitogen-activated protein kinases. The role of oxidative stress in the activation of mitogen-activated protein kinases by phenolic antioxidants.	BCAR1 PTK2	1.59e-05	2	139	2	9360968
Pubmed	Targeting lysine demethylase 6B ameliorates ASXL1 truncation-mediated myeloid malignancies in preclinical models.	ASXL1 KDM6B	1.59e-05	2	139	2	37917239
Pubmed	ApcMin/+ mouse model of colon cancer: gene expression profiling in tumors.	APC DNMT1	1.59e-05	2	139	2	15486983
Pubmed	Gli regulates MUC5AC transcription in human gastrointestinal cells.	GLI1 MUC5AC	1.59e-05	2	139	2	25166306
Pubmed	Activation of Rac GTPase by p75 is necessary for c-jun N-terminal kinase-mediated apoptosis.	ARHGEF17 TIAM2 ARHGEF9 VAV2	1.62e-05	38	139	4	11756498
Pubmed	Ptch2/Gas1 and Ptch1/Boc differentially regulate Hedgehog signalling in murine primordial germ cell migration.	BOC GLI1 GLI3	1.74e-05	13	139	3	32332736
Pubmed	NRAGE, a p75 neurotrophin receptor-interacting protein, induces caspase activation and cell death through a JNK-dependent mitochondrial pathway.	ARHGEF17 TIAM2 ARHGEF9 VAV2	2.67e-05	43	139	4	12376548
Pubmed	Functional proteomics mapping of a human signaling pathway.	FLI1 ERCC6 THSD7A SASH1 TUSC3 PDCD7 RYR2 YLPM1 PKD1 AFDN PLEC	2.74e-05	591	139	11	15231748
Pubmed	A predictive model of bifunctional transcription factor signaling during embryonic tissue patterning.	BOC GLI1 GLI3	2.74e-05	15	139	3	25458012
Pubmed	Fgfr2 is integral for bladder mesenchyme patterning and function.	BOC GLI1 COL1A1	2.74e-05	15	139	3	28052872
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	ACACA COL26A1 C11orf54 CD2AP TUSC3 BCAR1 CPT1A PTK2 SHC2 PTPRS NFIB ABCC8 TLE3 ARHGEF9 RASEF RERE ZSWIM4 VAV2	2.87e-05	1489	139	18	28611215
Pubmed	The ciliary Evc/Evc2 complex interacts with Smo and controls Hedgehog pathway activity in chondrocytes by regulating Sufu/Gli3 dissociation and Gli3 trafficking in primary cilia.	TCF7 GLI1 GLI3	3.37e-05	16	139	3	23026747
Pubmed	The Eyes Absent family members EYA4 and EYA1 promote PLK1 activation and successful mitosis through tyrosine dephosphorylation.	ATN1 C15orf39 ZC3H3 YJU2B ZMIZ2 R3HDM1	3.51e-05	152	139	6	38360978
Pubmed	A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation.	ACACA CD2AP APC ADAR THOC5 PTK2 FAM193A YLPM1 BOP1 PLEC R3HDM1 WDR48	3.63e-05	724	139	12	36232890
Pubmed	Activin A Determines Steroid Levels and Composition in the Fetal Testis.	SOX8 ITIH5 GLI1 ARHGEF9	3.81e-05	47	139	4	32274496
Pubmed	The human cytoplasmic dynein interactome reveals novel activators of motility.	ARHGAP32 ACACA SEC24A CD2AP PKD1L1 APC AP4E1 MEIOC TIMM50 RASEF AFDN PLEC BRWD1	4.04e-05	853	139	13	28718761
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	ASXL1 ARHGEF17 TLE3 ARHGEF9 NAV3 RERE R3HDM1 SEZ6L WDR48	4.05e-05	407	139	9	12693553
Pubmed	Jmjd3 Plays Pivotal Roles in the Proper Development of Early-Born Retinal Lineages: Amacrine, Horizontal, and Retinal Ganglion Cells.	FOXN4 KDM6B EOMES	4.08e-05	17	139	3	32986815
Pubmed	Long bone development requires a threshold of Hox function.	GLI1 GLI3 COL1A1	4.08e-05	17	139	3	24930703
Pubmed	Proteoglycan interactions with Sonic Hedgehog specify mitogenic responses.	EXT2 GLI1 GLI3	4.08e-05	17	139	3	19287388
Pubmed	Complexes of focal adhesion kinase (FAK) and Crk-associated substrate (p130(Cas)) are elevated in cytoskeleton-associated fractions following adhesion and Src transformation. Requirements for Src kinase activity and FAK proline-rich motifs.	BCAR1 PTK2	4.75e-05	3	139	2	9038154
Pubmed	Fuzzy modeling reveals a dynamic self-sustaining network of the GLI transcription factors controlling important metabolic regulators in adult mouse hepatocytes.	GLI1 GLI3	4.75e-05	3	139	2	26010061
Pubmed	Interaction of the leucine-rich repeats of polycystin-1 with extracellular matrix proteins: possible role in cell proliferation.	PKD1 COL1A1	4.75e-05	3	139	2	11752017
Pubmed	ACACA reduces lipid accumulation through dual regulation of lipid metabolism and mitochondrial function via AMPK- PPARα- CPT1A axis.	ACACA CPT1A	4.75e-05	3	139	2	38395901
Pubmed	Tyrosine phosphorylation of paxillin, FAK, and p130CAS: effects on cell spreading and migration.	BCAR1 PTK2	4.75e-05	3	139	2	11779709
Pubmed	EphrinA1-induced cytoskeletal re-organization requires FAK and p130(cas).	BCAR1 PTK2	4.75e-05	3	139	2	12134157
Pubmed	Bivalent Motif-Ear Interactions Mediate the Association of the Accessory Protein Tepsin with the AP-4 Adaptor Complex.	TEPSIN AP4E1	4.75e-05	3	139	2	26542808
Pubmed	GLI1 is a central mediator of EWS/FLI1 signaling in Ewing tumors.	FLI1 GLI1	4.75e-05	3	139	2	19859563
Pubmed	GLI1 facilitates the migration and invasion of pancreatic cancer cells through MUC5AC-mediated attenuation of E-cadherin.	GLI1 MUC5AC	4.75e-05	3	139	2	20972463
Pubmed	Interaction between focal adhesion kinase and Crk-associated tyrosine kinase substrate p130Cas.	BCAR1 PTK2	4.75e-05	3	139	2	7479864
Pubmed	Brachyphalangy, an allele of extra-toes in the mouse.	GLI1 GLI3	4.75e-05	3	139	2	5806166
Pubmed	Visualization of individual cell division history in complex tissues using iCOUNT.	GLI1 COL1A1	4.75e-05	3	139	2	34525348
Pubmed	Atrophin proteins interact with the Fat1 cadherin and regulate migration and orientation in vascular smooth muscle cells.	ATN1 RERE	4.75e-05	3	139	2	19131340
Pubmed	Reduction of pancreatic acinar cell tumor multiplicity in Dnmt1 hypomorphic mice.	APC DNMT1	4.75e-05	3	139	2	21362628
Interaction	SOCS6 interactions	ERBB4 ACACA BCAR1 ZMIZ2 TIMM50 CDK5RAP2 AFDN PLEC WDR48	2.61e-07	130	137	9	int:SOCS6
Interaction	SP7 interactions	FLI1 ATN1 C15orf39 PCF11 NFIB TLE3 ZMIZ2 SLC25A13 YLPM1 TIMM50 RERE	7.54e-06	304	137	11	int:SP7
Interaction	NCK2 interactions	ARHGAP32 ERBB4 ATN1 WIPF3 ANKS1B BCAR1 PTK2 YLPM1 PKD1 AFDN	1.25e-05	262	137	10	int:NCK2
Interaction	PKD1 interactions	BCAR1 PTK2 PTPRS PKD1 COL1A1	2.98e-05	53	137	5	int:PKD1
Interaction	PAX9 interactions	FLI1 TEPSIN ATN1 C15orf39 NFIB TLE3 ZMIZ2	3.03e-05	130	137	7	int:PAX9
Interaction	DLX5 interactions	FOXJ2 SOX8 HNF4G FOXI2	4.25e-05	29	137	4	int:DLX5
Interaction	EYA4 interactions	FOXJ2 ERCC6 ATN1 C15orf39 ZC3H3 YJU2B ZMIZ2 PLEC R3HDM1	4.36e-05	243	137	9	int:EYA4
Interaction	CRK interactions	ARHGAP32 ERBB4 SASH1 CD2AP DOK3 BCAR1 KMT2E PTK2 SLC25A13 PLEC VAV2	4.63e-05	370	137	11	int:CRK
Interaction	TLE3 interactions	FOXJ2 ATN1 SEC24A C15orf39 FAM193A PAX8 NFIB TLE3 ZMIZ2 RERE COL1A1	5.35e-05	376	137	11	int:TLE3
Interaction	HDAC1 interactions	SFMBT1 ERCC6 ACACA CD2AP APC C15orf39 ZNF395 ZFPM1 SOX8 KMT2E THOC5 NFATC2 GLI1 GLI3 TLE3 ZMIZ2 CDK5RAP2 RERE PLEC DNMT1	6.03e-05	1108	137	20	int:HDAC1
Cytoband	8q24.3	ZC3H3 PTK2 ARC BOP1 SLC52A2	2.56e-05	113	139	5	8q24.3
Cytoband	15q24.2	C15orf39 SNX33 SNUPN	1.26e-04	32	139	3	15q24.2
Cytoband	Ensembl 112 genes in cytogenetic band chr15q24	C15orf39 SNX33 SNUPN NEO1	5.36e-04	122	139	4	chr15q24
Cytoband	Ensembl 112 genes in cytogenetic band chr8q24	ZC3H3 PTK2 ARC BOP1 PLEC SLC52A2	7.77e-04	355	139	6	chr8q24
GeneFamily	Fibronectin type III domain containing	BOC SDK2 DSCAML1 FNDC1 NEO1 PTPRS	2.22e-04	160	97	6	555
GeneFamily	Nuclear factors of activated T-cells	NFATC2 NFATC4	2.82e-04	5	97	2	665
GeneFamily	Pleckstrin homology domain containing\|Rho guanine nucleotide exchange factors\|C2 domain containing	ARHGEF17 TIAM2 ARHGEF9 VAV2	4.35e-04	66	97	4	722
GeneFamily	Forkhead boxes	FOXJ2 FOXN4 FOXI2	1.58e-03	43	97	3	508
GeneFamily	Blood group antigens\|CD molecules\|I-set domain containing\|Immunoglobulin like domain containing	BOC SDK2 DSCAML1 NEO1 PTPRS	1.75e-03	161	97	5	593
Coexpression	HAY_BONE_MARROW_STROMAL	BOC FMO3 TUSC3 BCAR1 ARHGEF17 ITIH5 FNDC1 SHC2 NFATC4 NFIB FZD5 GLI3 ABCC8 NAV3 C7 COL1A1	3.30e-06	767	139	16	M39209
Coexpression	MIKKELSEN_MEF_HCP_WITH_H3K27ME3	SLC46A2 FOXN4 CPN1 DSCAML1 RYR2 HOXB3 PAX8 ABCC8 LYPD3 DISP3 RASEF BSN SEZ6L CA4	3.33e-06	591	139	14	M2019
Coexpression	MIKKELSEN_MEF_HCP_WITH_H3K27ME3	SLC46A2 FOXN4 CPN1 DSCAML1 RYR2 HOXB3 PAX8 ABCC8 LYPD3 DISP3 RASEF BSN SEZ6L CA4	4.04e-06	601	139	14	MM866
Coexpression	MEISSNER_BRAIN_HCP_WITH_H3K4ME3_AND_H3K27ME3	FLI1 SASH1 COL26A1 SNX33 PRSS23 CPT1A ARHGEF17 NFATC2 EGR3 NFIB FZD5 GLI3 SLC25A13 RASEF SPSB4 VAV2 SEZ6L CA4 PEAR1	4.17e-06	1074	139	19	M1941
Coexpression	BROWNE_HCMV_INFECTION_2HR_DN	NPTX1 ERCC6 PRIM2 YLPM1 PLAUR	5.56e-06	48	139	5	M521
Coexpression	GSE25123_CTRL_VS_IL4_STIM_PPARG_KO_MACROPHAGE_DN	FOXN4 ARHGAP30 DTX3L ADAR NEO1 RBFOX1 ARHGEF9 PLS1	1.15e-05	199	139	8	M7976
Coexpression	GSE29618_PRE_VS_DAY7_POST_TIV_FLU_VACCINE_PDC_UP	FOXJ2 ACACA VWA7 HNF4G NFATC4 FZD5 PLS1 LILRB5	1.20e-05	200	139	8	M5003
Coexpression	LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_SMALL_VS_HUGE_DN	NPTX1 APC PDCD7 WDR48	2.75e-05	33	139	4	M19655
Coexpression	LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_SMALL_VS_HUGE_DN	NPTX1 APC PDCD7 WDR48	3.49e-05	35	139	4	MM542
Coexpression	GSE37301_PRO_BCELL_VS_RAG2_KO_NK_CELL_DN	ASXL1 ITIH5 RPS6KC1 PTPRS SLC25A13 VAV2 PEAR1	4.93e-05	179	139	7	M8900
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN	SFMBT1 ASXL1 SASH1 SEC24A CD2AP APC PTK2 PCF11 FAM193A NFIB SLC25A13 PRIM2 NAV3 PLAUR R3HDM1	5.15e-05	856	139	15	M4500
Coexpression	DESCARTES_ORGANOGENESIS_GRANULE_NEURONS	TIAM2 EOMES NFIB ABCC8	6.59e-05	41	139	4	MM3647
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_DN	SFMBT1 ASXL1 FAM193A NFIB NAV3	8.61e-05	84	139	5	M13008
Coexpression	GSE11961_GERMINAL_CENTER_BCELL_DAY7_VS_PLASMA_CELL_DAY7_UP	ATN1 SASH1 PGPEP1 ARHGAP30 DTX3L DSCAML1 NFATC4	9.89e-05	200	139	7	M9360
Coexpression	GSE11961_MARGINAL_ZONE_BCELL_VS_MEMORY_BCELL_DAY40_UP	CD2AP GLI1 PKD1 STARD3 ARC VAV2 COL1A1	9.89e-05	200	139	7	M9324
Coexpression	GSE43955_1H_VS_20H_ACT_CD4_TCELL_DN	SGIP1 SASH1 CPN1 PRSS23 PTPRS NFIB GLI3	9.89e-05	200	139	7	M9662
Coexpression	GSE43863_TH1_VS_TFH_MEMORY_CD4_TCELL_DN	ZNF395 PRSS23 CPT1A GLI3 PRIM2 RERE PLEC	9.89e-05	200	139	7	M9735
ToppCell	Mesenchymal\|World / Lineage, Cell type, age group and donor	BOC SGIP1 RYR2 HOXB3 PTPRS NFIB GLI3 NAV3 C7 COL1A1	6.91e-10	199	138	10	4bac110c2b3609f6ee5d0e3275da0824a6240270
ToppCell	droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial-Enterocyte\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	C11orf54 CD2AP CPN1 CREB3L3 PLEC TMC5 PLS1 CA4	7.37e-08	174	138	8	2fbdb62e269acf4447b171700a615e878dde7f9f
ToppCell	droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial-enterocyte_of_epithelium_of_large_intestine\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	C11orf54 CD2AP CPN1 CREB3L3 PLEC TMC5 PLS1 CA4	7.37e-08	174	138	8	7c52b5d8f1e65e5208c952be341fa155ed0e6e76
ToppCell	5'-GW_trimst-2-LymphNode-Mesenchymal-fibroblastic-Stromal_3_(C7+)\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	BOC COL26A1 PRSS23 NFIB NAV3 C7 PEAR1 COL1A1	1.13e-07	184	138	8	4d4d8f3f44c67d74c57e7af7b7c158f0157b2f49
ToppCell	primary_visual_cortex-Neuronal-glutamatergic_neuron\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	ARHGAP32 NPTX1 PTK2 RYR2 TIAM2 EGR3 ARC R3HDM1	1.23e-07	186	138	8	56c139e679d640ea901ead657a8e8887e0fca098
ToppCell	Adult-Mesenchymal-matrix_fibroblast_2_cell\|Adult / Lineage, Cell type, age group and donor	BOC HOXB3 NFATC4 PTPRS GLI3 NAV3 C7 COL1A1	1.57e-07	192	138	8	d21f0f577156f17c899b08871046a26b88aea011
ToppCell	facs-MAT-Fat-3m-Mesenchymal-mesenchymal_stem_cell_of_adipose\|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	BOC SASH1 PRSS23 ITIH5 FNDC1 NFIB C7 COL1A1	1.63e-07	193	138	8	f95b95c58a6edb8a03dd15ae166f47f9f33d8bd6
ToppCell	facs-MAT-Fat-3m-Mesenchymal-mesenchymal_progenitor\|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	BOC SASH1 PRSS23 ITIH5 FNDC1 NFIB C7 COL1A1	1.63e-07	193	138	8	85faf6c5ce4769615a4eca036e2ba307e176bb52
ToppCell	facs-MAT-Fat-3m-Mesenchymal\|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	BOC SASH1 PRSS23 ITIH5 FNDC1 NFIB C7 COL1A1	1.63e-07	193	138	8	110a7d2ba7d066c2be38be98b643b76c520dd980
ToppCell	PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	SGIP1 THSD7A ANKS1B HOXB3 NEO1 GLI3 RERE C7	1.77e-07	195	138	8	0e55fa5b3cbeb7baee3d4ac272a3bf80381ec937
ToppCell	10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-Pericyte\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	TUSC3 PRSS23 ARHGEF17 ITIH5 C7 CA4 PEAR1 COL1A1	1.84e-07	196	138	8	7acd782a587b7d331517f60daa8b5c2177bedfc7
ToppCell	Children_(3_yrs)-Mesenchymal\|Children_(3_yrs) / Lineage, Cell type, age group and donor	BOC SGIP1 RYR2 PTPRS NFIB NAV3 C7 COL1A1	1.84e-07	196	138	8	bc94909f9b2dc08a59eef1914148b69720569c8f
ToppCell	10x3'2.3-week_17-19-Endothelial-stroma-tip_EC\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	THSD7A SASH1 TUSC3 BCAR1 SHC2 NFIB AFDN PEAR1	1.91e-07	197	138	8	b212ff28ca2d1fea4140f186ab90941bdca21249
ToppCell	COVID-19-Fibroblasts\|COVID-19 / group, cell type (main and fine annotations)	SGIP1 RYR2 PTPRS NFIB GLI3 NAV3 C7 COL1A1	1.91e-07	197	138	8	fb847f2277609c31fffcdf49517243ce0684facf
ToppCell	Parenchymal-10x5prime-Stromal-Fibroblastic-Fibro_peribronchial\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	BOC SDK2 FMO3 ITIH5 NFATC4 GLI1 C7 COL1A1	1.99e-07	198	138	8	300d7cc56207d77168390fa1ffcbcf76767b1b80
ToppCell	Adult-Mesenchymal\|Adult / Lineage, Cell type, age group and donor	BOC SGIP1 RYR2 HOXB3 PTPRS NAV3 C7 COL1A1	1.99e-07	198	138	8	26e55b409db2a1637c95fae7c54b0abea1ef550c
ToppCell	Fetal_29-31_weeks-Mesenchymal\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	BOC SGIP1 RYR2 HOXB3 NFIB GLI3 C7 COL1A1	1.99e-07	198	138	8	21cf4d81386761d09d0f6829c01c198e5524176d
ToppCell	Bronchial-NucSeq-Stromal\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	BOC SGIP1 RYR2 HOXB3 PTPRS NAV3 C7 COL1A1	2.15e-07	200	138	8	389cc775c8419d90fb77cd794376d2160a7bf44e
ToppCell	Brain_organoid-organoid_Tanaka_cellReport-6m-Neuronal-Neuron\|6m / Sample Type, Dataset, Time_group, and Cell type.	THSD7A SOX8 KDM6B EOMES HOXB3 CELF3 AFDN SEZ6L	2.15e-07	200	138	8	b5019b9d48f32cffd4645a5c0f3e0ac504ea8019
ToppCell	368C-Fibroblasts-Fibroblast-E\|368C / Donor, Lineage, Cell class and subclass (all cells)	BOC ERCC6 PTPRS NAV3 DISP3 C7 COL1A1	7.52e-07	162	138	7	e17632778a57c71d6005d3abca3a0443a92040e7
ToppCell	368C-Fibroblasts-Fibroblast-E-\|368C / Donor, Lineage, Cell class and subclass (all cells)	BOC ERCC6 PTPRS NAV3 DISP3 C7 COL1A1	7.52e-07	162	138	7	ac4a80fd72c9311ea2b3e574c6284bbce4f2756c
ToppCell	367C-Myeloid-Macrophage-FABP4+_Macrophage_3\|Myeloid / Donor, Lineage, Cell class and subclass (all cells)	THSD7A HPDL DSCAML1 SHC2 NFATC4 NFIB GLI3	8.85e-07	166	138	7	f416d8a322f086c769659a9fab6b460a2d546ab1
ToppCell	367C-Myeloid-Macrophage-FABP4+_Macrophage_3\|Macrophage / Donor, Lineage, Cell class and subclass (all cells)	THSD7A HPDL DSCAML1 SHC2 NFATC4 NFIB GLI3	9.22e-07	167	138	7	5c82d801e3b7d7c6c967a73b94b2ee2a8da1fd6e
ToppCell	10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-Pericyte-B\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	FMO3 ARHGEF17 RYR2 ITIH5 CA4 PEAR1 COL1A1	1.08e-06	171	138	7	a4a2c5dc995589fbe3d4ca6ee1df888807e4ae34
ToppCell	Mid-temporal_gyrus_(MTG)-Non-neuronal-Mesenchymal-Mes-Myofibroblast\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	KREMEN1 CPT1A ITIH5 NFATC4 C7 PEAR1 COL1A1	1.41e-06	178	138	7	1802ff1c6cb18ee62cfef7270c0971048fae5315
ToppCell	Mid-temporal_gyrus_(MTG)-Non-neuronal-Mesenchymal-Mes-Myofibroblast-VLMC_L1-3_CYP1B1\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	KREMEN1 CPT1A ITIH5 NFATC4 C7 PEAR1 COL1A1	1.41e-06	178	138	7	4368d20130e5a08716564c19470b6014f16902ac
ToppCell	E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_prolif\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	SFMBT1 MANEA PRSS23 ITIH5 GLI1 BOP1 COL1A1	1.47e-06	179	138	7	ce3ca7f3a5864e62307aa744a3173f350a90df28
ToppCell	normal_Lung-Fibroblasts-Pericytes\|normal_Lung / Location, Cell class and cell subclass	SGIP1 COL26A1 ARHGEF17 PTK2 RYR2 HOXB3 PEAR1	1.58e-06	181	138	7	f74941e49950027360d71ea3b205fc20c6929766
ToppCell	(2)_5-FU-(4)_COL2.3+_osteoblasts\|(2)_5-FU / Stress and Cell class	BOC TCF7 KREMEN1 NEO1 PTPRS PKD1 PLAUR	1.58e-06	181	138	7	56ae86072858c156681507aecd1bc6cb0a3372d2
ToppCell	5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	BOC TUSC3 ITIH5 FNDC1 NAV3 C7 COL1A1	1.64e-06	182	138	7	3dfa9187e9d2bab1d199079d29209c4648220ada
ToppCell	Control-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	BOC ANKS1B RYR2 FNDC1 PTPRS GLI1 RBFOX1	1.70e-06	183	138	7	7eae9b3b4d1c9b135fa7cff348393d4adec474b4
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	BOC SGIP1 THSD7A SASH1 COL26A1 DSCAML1 PAX8	1.76e-06	184	138	7	da06ff24ee2b2cf4715fdfce43030b2da9e0aaf8
ToppCell	5'-Adult-Distal_Rectal-Mesenchymal-fibroblastic-mLN_Stroma_(FMO2+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	BOC FMO3 ARHGEF17 NFATC4 PTPRS GLI1 C7	1.83e-06	185	138	7	9faa35ceb89ccd2979072286f063687c9f846ce3
ToppCell	droplet-Lung-nan-21m-Endothelial-endothelial_cell_of_lymphatic_vessel\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	WIPF3 PRSS23 ITIH5 CDKL5 EGR3 NAV3 PEAR1	1.83e-06	185	138	7	3a4ae836e882e8d29eb0a2dfab5677f10f2d365f
ToppCell	Adult-Mesenchymal-matrix_fibroblast_2_cell-D231\|Adult / Lineage, Cell type, age group and donor	BOC HOXB3 NFATC4 PTPRS NAV3 C7 COL1A1	1.83e-06	185	138	7	fb6bd7e849ecf4ed9cd9c4e2a946a2d12d62f804
ToppCell	droplet-Lung-nan-21m-Endothelial-Lymphatic_endothelial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	WIPF3 PRSS23 ITIH5 CDKL5 EGR3 NAV3 PEAR1	1.83e-06	185	138	7	224f0b022c21dd40bf1f7503f00b3107ef958975
ToppCell	droplet-Lung-LUNG-30m-Endothelial-endothelial_cell_of_lymphatic_vessel\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	THSD7A WIPF3 C15orf39 PRSS23 ITIH5 NAV3 PEAR1	1.89e-06	186	138	7	f23f21781a758541f59c06efa7739d26a03fb478
ToppCell	droplet-Lung-LUNG-30m-Endothelial-Lymphatic_endothelial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	THSD7A WIPF3 C15orf39 PRSS23 ITIH5 NAV3 PEAR1	1.89e-06	186	138	7	0de87109da9324c597fadf2eb782f0f158afe832
ToppCell	Control-Fibroblasts-Other_FB\|Control / group, cell type (main and fine annotations)	BOC SGIP1 RYR2 ITIH5 HOXB3 NAV3 C7	1.96e-06	187	138	7	bd3739c4a52aa1ba5deffd778e113a9800f7e158
ToppCell	E16.5-samps-Mesenchymal\|E16.5-samps / Age Group, Lineage, Cell class and subclass	BOC HOXB3 NEO1 PTPRS NFIB GLI1 COL1A1	2.03e-06	188	138	7	3f0f662be684e3a4c6652e636cc135a39a1d2790
ToppCell	Severe_COVID-19-Epithelial-undefined_Epi\|Severe_COVID-19 / Disease group,lineage and cell class （2021.01.30）	THSD7A ZNF395 PRSS23 BCAR1 RASEF TMC5 MUC5AC	2.10e-06	189	138	7	8cbd35320c7e7ff013ef0c0f13f8d875db1c53cd
ToppCell	facs-Mammary_Gland-Mammary_Gland-18m-Epithelial\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	BOC FLI1 KDM6B VWA7 PCF11 EGR3 NFIB	2.18e-06	190	138	7	92456f6f7eced6e4c4371f495254a65d061c8d0b
ToppCell	droplet-Lung-21m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell\|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	WIPF3 PRSS23 ITIH5 CDKL5 NAV3 CREB3L3 PEAR1	2.18e-06	190	138	7	f50b9814a1beac67dc042a8c27dfd085ceeda3a6
ToppCell	droplet-Lung-21m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell\|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	WIPF3 PRSS23 ITIH5 CDKL5 NAV3 CREB3L3 PEAR1	2.18e-06	190	138	7	a22a510b4a257eb0eaf09c7ae7978d3d2f07a58c
ToppCell	droplet-Lung-21m-Endothelial-lymphatic_endothelial\|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	WIPF3 PRSS23 ITIH5 CDKL5 NAV3 CREB3L3 PEAR1	2.18e-06	190	138	7	57c136bf6d7feafb4a220877bed0cc8fdf314db2
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Inner_Medullary_Collecting_Duct_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	CD2AP ANKS1B HOXB3 PAX8 NFIB AFDN TMC5	2.26e-06	191	138	7	3e828cffa24ded19f591a7ed6c1fe88ad57fdcac
ToppCell	nucseq-Endothelial-Endothelial_Vascular-Endothelial_large_blood_vessel-AEC\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	THSD7A SASH1 TUSC3 PRSS23 PTK2 NFIB ARC	2.26e-06	191	138	7	50601ef0a5a8f2c2120922989e08e85bf2d9b4ab
ToppCell	facs-Heart-LV-3m-Mesenchymal\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	THSD7A COL26A1 PRSS23 ARHGEF17 ITIH5 FNDC1 COL1A1	2.26e-06	191	138	7	b7a57691a4742070cee640e285c1f4d0da95baf1
ToppCell	facs-Lung-nan-3m-Endothelial-Lymphatic_endothelial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	THSD7A WIPF3 PRSS23 ITIH5 NAV3 SEZ6L PEAR1	2.26e-06	191	138	7	48823a97c38263f2c6e58348214f5b62773a6368
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	FLI1 FMO3 PRSS23 FNDC1 GLI3 C7 COL1A1	2.26e-06	191	138	7	39092a0aff8097617820c59f5fea9ee2bb4f63a2
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	SGIP1 ARHGEF17 NFATC4 GLI3 C7 PEAR1 COL1A1	2.26e-06	191	138	7	7b0d42a877540dbb346a76a62403e0d5d3e07fa6
ToppCell	facs-Lung-nan-3m-Endothelial-endothelial_cell_of_lymphatic_vessel\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	THSD7A WIPF3 PRSS23 ITIH5 NAV3 SEZ6L PEAR1	2.26e-06	191	138	7	0eedc66e967b1837ce2c14f8c14b3c1eba868c76
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	FLI1 FMO3 PRSS23 FNDC1 GLI3 C7 COL1A1	2.26e-06	191	138	7	ee5f1b1c59029c46cbb1a00935c03b9317bb9da9
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	SGIP1 ARHGEF17 NFATC4 GLI3 C7 PEAR1 COL1A1	2.26e-06	191	138	7	cd854b9c426924fdc84bf7f411f6dea447143e79
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	BOC FMO3 PRSS23 GLI3 NAV3 C7 COL1A1	2.34e-06	192	138	7	5105e4b577408b4e1a62d0a44c23c2b830ccad88
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Pericyte\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	TUSC3 PRSS23 ARHGEF17 NFATC4 CA4 PEAR1 COL1A1	2.34e-06	192	138	7	09cb5b89a164ac7444774ccc8c90323c8ea2026b
ToppCell	facs-Mammary_Gland-Mammary_Gland-18m-Epithelial-basal_cell\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	BOC FLI1 KDM6B VWA7 PCF11 EGR3 ARC	2.34e-06	192	138	7	c47df468cf78a90929913c9022e8078a53cdf680
ToppCell	LPS-antiTNF-Endothelial-Endothelial-Gen_Cap\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	FLI1 THSD7A SASH1 PTK2 NFIB AFDN CA4	2.42e-06	193	138	7	6e1982d089a9de628e6006d23ff78a223fbd9f47
ToppCell	nucseq-Endothelial-Endothelial_Vascular-Endothelial_large_blood_vessel-VEC\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	FLI1 SASH1 PRSS23 NFIB ABCC8 NAV3 C7	2.42e-06	193	138	7	9ba688b35a9ead5d04691b3f3f15484f02dbbd0d
ToppCell	COVID-19-Fibroblasts-Other_FB\|COVID-19 / group, cell type (main and fine annotations)	BOC SGIP1 RYR2 HOXB3 GLI3 NAV3 COL1A1	2.42e-06	193	138	7	e6b75be08e33c1de079fb5c02f0b4468128b369c
ToppCell	10x3'2.3-week_14-16-Mesenchymal_fibro-stroma-arteriolar_fibroblast\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	BOC CPN1 PRSS23 ITIH5 FNDC1 NFIB SPSB4	2.42e-06	193	138	7	09de51f8ac509e03d480ed3dc9dfe7e7defc59cb
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	TUSC3 PRSS23 ARHGEF17 ITIH5 CA4 PEAR1 COL1A1	2.42e-06	193	138	7	dd4bac8a93a5b9dcf7301f1d7d6e3eb6670f5c68
ToppCell	Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_perichondrial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	NPTX1 FOXN4 HNF4G HOXB3 EGR3 NAV3 SPSB4	2.42e-06	193	138	7	e5016959f24370579a8770787e96869f264cf7b3
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	TUSC3 PRSS23 ARHGEF17 ITIH5 CA4 PEAR1 COL1A1	2.42e-06	193	138	7	2ddf9b2770a0be9689e01d1a3d19e4a6d42c7a50
ToppCell	nucseq-Endothelial-Endothelial_Vascular-Endothelial_capillary-CAP1\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	FLI1 SASH1 PRSS23 NFIB ABCC8 NAV3 CA4	2.42e-06	193	138	7	ad3f4fcc8e2816d696cbcde744dc16500e51ccac
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	FLI1 FMO3 PRSS23 NFATC4 PTPRS GLI3 C7	2.50e-06	194	138	7	81713e0409e8be695ba5dfdc67a997b33435dd9e
ToppCell	Control-Fibroblasts-Intermediate_pathological_FB\|Control / group, cell type (main and fine annotations)	SGIP1 RYR2 FNDC1 GLI3 NAV3 C7 COL1A1	2.50e-06	194	138	7	03a269f75a481ea54aea8e6444605db8d6df493d
ToppCell	nucseq-Mesenchymal-Myocytic\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	SGIP1 ARHGEF17 RYR2 HOXB3 FNDC1 GLI3 COL1A1	2.50e-06	194	138	7	2d66091097e106c7bee22e5281f50724700bdf8d
ToppCell	COPD-Endothelial-VE_Capillary_B\|World / Disease state, Lineage and Cell class	SASH1 TUSC3 PRSS23 NFIB ABCC8 NAV3 CA4	2.50e-06	194	138	7	68705a6eca947c5b42b943d5224a7aef2a744007
ToppCell	Brain_organoid-organoid_Paulsen_bioRxiv-6_mon-IPC_like-IPCs\|6_mon / Sample Type, Dataset, Time_group, and Cell type.	NPTX1 CDHR1 WIPF3 SOX8 EOMES PTPRS SEZ6L	2.50e-06	194	138	7	2378a98452f6ec33870eeb994b8b812e9b507f4c
ToppCell	Brain_organoid-organoid_Paulsen_bioRxiv-6_mon-IPC_like\|6_mon / Sample Type, Dataset, Time_group, and Cell type.	NPTX1 CDHR1 WIPF3 SOX8 EOMES PTPRS SEZ6L	2.50e-06	194	138	7	7ba0445a486feac18b3a4fd6f2855c102e374e2d
ToppCell	COPD-Endothelial-VE_Capillary_B\|COPD / Disease state, Lineage and Cell class	SASH1 TUSC3 PRSS23 NFIB ABCC8 NAV3 CA4	2.50e-06	194	138	7	18b7f901c12ca4f21f9a1eafd092aefe4d668b6d
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	FLI1 FMO3 PRSS23 NFATC4 PTPRS GLI3 C7	2.50e-06	194	138	7	627cffe2d448e74fc5df92e74e5b922a73304137
ToppCell	Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	PTPRS NFIB GLI3 NAV3 C7 DNMT1 COL1A1	2.59e-06	195	138	7	ff0aa455e9844a6d7ae57ff59fb6cea825cf1fc2
ToppCell	COVID-19-Fibroblasts-Alveolar_FB\|COVID-19 / group, cell type (main and fine annotations)	SGIP1 RYR2 ITIH5 PTPRS NFIB NAV3 C7	2.59e-06	195	138	7	603050beeb33c331d4b2e3fa46cae3f3e0e4bdc7
ToppCell	facs-Mammary_Gland-Mammary_Gland-18m-Epithelial-basal_cell\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	BOC FLI1 KDM6B VWA7 PCF11 EGR3 ARC	2.59e-06	195	138	7	f41a68b7c2621594db8d8952e301eeadc96be26f
ToppCell	Bronchial-NucSeq-Epithelial-Epi_airway_secretory\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ARHGAP32 ERBB4 PRSS23 HNF4G PTK2 TMC5 MUC5AC	2.59e-06	195	138	7	e7230a849ea31e6eef9bc6f5468938499450582d
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ARHGAP32 NPTX1 RYR2 CDKL5 RBFOX1 NAV3 R3HDM1	2.59e-06	195	138	7	2e1df01bf6e4e98e6cd9fb50926e34c5077b8666
ToppCell	nucseq-Endothelial-Endothelial_Vascular\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	FLI1 SASH1 TUSC3 PRSS23 PTK2 NFIB CA4	2.68e-06	196	138	7	686533fd3fba8e4df96b9dd1307e870e89db4332
ToppCell	5'-Adult-Appendix-Mesenchymal-fibroblastic\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	BOC FMO3 KDM6B PTPRS ARC C7 COL1A1	2.77e-06	197	138	7	ab5d3ebc73bd7cfc64381d14b92878b370205186
ToppCell	5'-GW_trimst-2-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	BOC COL26A1 NFIB GLI3 NAV3 C7 COL1A1	2.77e-06	197	138	7	2744cc94883c5d0424677cf5093bbab622933e9b
ToppCell	COVID-19-lung-Fibroblast\|COVID-19 / Disease (COVID-19 only), tissue and cell type	SGIP1 RYR2 PTPRS GLI3 NAV3 C7 COL1A1	2.86e-06	198	138	7	3ec01a55ade5e1627258cc3cfebb2c3207a4cb43
ToppCell	10x3'2.3-week_17-19-Endothelial\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	THSD7A SASH1 BCAR1 SHC2 NFIB AFDN PEAR1	2.86e-06	198	138	7	2630a7a6e56febe5c0b0bde70dd7292fa1650c47
ToppCell	COVID-19-lung-Fibroblast\|lung / Disease (COVID-19 only), tissue and cell type	SGIP1 RYR2 PTPRS GLI3 NAV3 C7 COL1A1	2.86e-06	198	138	7	df3de77216f5c5d6141ec44d01c56b942f611838
ToppCell	droplet-Limb_Muscle-MUSCLE-1m-Mesenchymal-chondrocyte-like\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	BOC FNDC1 NEO1 NFATC2 PTPRS CREB3L3 COL1A1	2.86e-06	198	138	7	524305c5d7b1d53e86ec0af775efefa3e0955e47
ToppCell	10x3'2.3-week_17-19-Endothelial-stroma\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	THSD7A SASH1 BCAR1 SHC2 NFIB AFDN PEAR1	2.86e-06	198	138	7	1e83bec16dcd60460422625f89952ff506d6be51
ToppCell	3'-GW_trimst-2-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	BOC COL26A1 PRSS23 NFIB NAV3 C7 COL1A1	2.96e-06	199	138	7	bfc157be6e9f84739848eb19b718de5b17f3fa88
ToppCell	3'-Child04-06-SmallIntestine-Mesenchymal-Pericytes-Pericyte\|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	FMO3 SGIP1 PRSS23 ARHGEF17 PTK2 PEAR1 COL1A1	2.96e-06	199	138	7	bd9b36dcf61eaa628ce1b70d21c5783b64c29e8f
ToppCell	3'-Child04-06-SmallIntestine-Mesenchymal-Pericytes\|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	FMO3 SGIP1 PRSS23 ARHGEF17 PTK2 PEAR1 COL1A1	2.96e-06	199	138	7	e751eb67510f8a5842dcfed44134160919cdb713
ToppCell	wk_15-18-Mesenchymal-Fibroblast-Alveolar_fibro\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	THSD7A ANKS1B ITIH5 NFIB AFDN C7 COL1A1	2.96e-06	199	138	7	6bce8e65859a35cfea1c210f9c9765952d492ed2
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW10\|organoid_Tanaka_cellReport / Sample Type, Dataset, Time_group, and Cell type.	BOC NPTX1 THSD7A EOMES NFATC4 NFIB GLI3	3.06e-06	200	138	7	7c495030e6566b81d97b5516d1972e335ce5ed8c
ToppCell	Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_alveolar\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	SGIP1 RYR2 ITIH5 HOXB3 PTPRS NAV3 C7	3.06e-06	200	138	7	e8462395fee0a532d1e7ec7f1795f28c42af6541
ToppCell	Parenchyma_Control_(B.)-Stromal-TX-Fibroblasts-1\|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type	SDK2 FMO3 RYR2 PTPRS NAV3 C7 COL1A1	3.06e-06	200	138	7	aa1a35dcca3b799241eef4237f6eb94660e019f0
ToppCell	Tracheal-10x3prime_v2-Stromal-Pericyte-Muscle_pericyte_pulmonary\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	SGIP1 COL26A1 ARHGEF17 PTK2 RYR2 ITIH5 PEAR1	3.06e-06	200	138	7	8158f4eaeff945a6788c8e732b7a1b0d78052a06
ToppCell	Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	SDK2 FMO3 RYR2 PTPRS NAV3 C7 COL1A1	3.06e-06	200	138	7	a510deaada669e690329183e18df02870bd204b3
ToppCell	10x3'2.3-week_12-13-Mesenchymal_fibro-stroma\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	BOC PRSS23 FNDC1 NFIB SPSB4 CA4 COL1A1	3.06e-06	200	138	7	64d2941689d7ca8af54f9ba21c5aeabf719084ef
ToppCell	Parenchymal-NucSeq-Stromal\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	SGIP1 RYR2 HOXB3 PTPRS NAV3 C7 COL1A1	3.06e-06	200	138	7	cf433f9b43d7db07acaf70e060f8f77c974e72f3
ToppCell	LPS_IL1RA-Endothelial-Endothelial-Alv_Gen_Intermediate\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	FLI1 SASH1 PTK2 ITIH5 NFIB AFDN PLEC	3.06e-06	200	138	7	b70b7adb7c187e6253c7f0bb4c1f09c85ef7142c
ToppCell	Tracheal-10x3prime_v2-Stromal-Pericyte\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	SGIP1 COL26A1 ARHGEF17 PTK2 RYR2 ITIH5 PEAR1	3.06e-06	200	138	7	600d56257b1b0cda8ed2fd0db92c6551711f7d6d
ToppCell	Neuronal-Excitatory\|Neuronal / cells hierarchy compared to all cells using T-Statistic	ARHGAP32 NPTX1 ANKS1B PTK2 RYR2 NAV3 R3HDM1	3.06e-06	200	138	7	4409065bc7aa995354c71e0f9d6f3726cf393d6b
Drug	(-)-Quinpirole hydrochloride [85760-74-3]; Down 200; 15.6uM; MCF7; HT_HG-U133A	NPTX1 ERCC6 ERP44 SASH1 APC RYR2 AP4E1 NFIB PLEC	2.93e-06	194	138	9	3539_DN
Drug	Mebendazole [31431-39-7]; Down 200; 13.6uM; PC3; HT_HG-U133A	ATN1 C15orf39 CPT1A KDM6B PCF11 NFIB ZMIZ2 LYPD3 WDR48	2.93e-06	194	138	9	3671_DN
Drug	quercetin dihydrate; Up 200; 1uM; MCF7; HG-U133A	SASH1 ARHGEF17 NFATC4 YJU2B ARHGEF9 PLEC VAV2 BRWD1 WDR48	3.18e-06	196	138	9	283_UP
Drug	Ipratropium bromide [22254-24-6]; Up 200; 9.8uM; PC3; HT_HG-U133A	NPTX1 APC PGPEP1 THOC5 RYR2 SHC2 PAX8 LYPD3 VAV2	3.32e-06	197	138	9	5823_UP
Drug	xylenol orange	ARHGAP32 RBFOX1 PLS1 COL1A1	5.81e-06	20	138	4	CID000073041
Drug	chlorothalonil	NPTX1 CHIA ATN1 ACACA ZNF395 EOMES RERE PLS1	6.70e-06	162	138	8	CID000015910
Drug	glycyl-l-prolylalanine	PGPEP1 GLI1 SEZ6L COL1A1	7.14e-06	21	138	4	CID000097052
Drug	CP-19	BCAR1 PTK2 COL1A1	1.19e-05	8	138	3	CID000467804
Drug	1-piperidinocyclohexanecarbonitrile	ACACA NEO1 PAX8 PLEC	1.48e-05	25	138	4	CID000062529
Drug	Ketoconazole [65277-42-1]; Up 200; 7.6uM; HL60; HT_HG-U133A	ASXL1 ACACA EXT2 ZC3H3 RYR2 EGR3 TLE3 RBFOX1	2.06e-05	189	138	8	1285_UP
Drug	Mecamylamine hydrochloride [826-39-1]; Down 200; 19.6uM; MCF7; HT_HG-U133A	TCF7 NPTX1 PGPEP1 KDM6B ZC3H3 RYR2 AP4E1 CDK5RAP2	2.57e-05	195	138	8	3525_DN
Drug	Phenazopyridine hydrochloride [136-40-3]; Down 200; 16uM; MCF7; HT_HG-U133A	ARHGAP32 TUSC3 CPT1A NFIB GLI3 TLE3 PLAUR RERE	2.57e-05	195	138	8	6234_DN
Drug	Clindamycin hydrochloride [21462-39-5]; Down 200; 8.6uM; MCF7; HT_HG-U133A	TCF7 C15orf39 KDM6B NFIB PLAUR PLEC TMC5 WDR48	2.57e-05	195	138	8	7172_DN
Drug	Dropropizine (R,S) [17692-31-8]; Down 200; 17uM; MCF7; HT_HG-U133A	ATN1 SASH1 C15orf39 PGPEP1 EXT2 PCF11 CDK5RAP2 PLEC	2.67e-05	196	138	8	7429_DN
Drug	Mephenesin [59-47-2]; Down 200; 22uM; MCF7; HT_HG-U133A	RYR2 PTPRS NFIB GLI3 TLE3 ARHGEF9 TMC5 COL1A1	2.77e-05	197	138	8	2304_DN
Drug	haloperidol; Down 200; 10uM; MCF7; HT_HG-U133A	TCF7 SASH1 YJU2B ARC UGGT2 TMC5 COL1A1 WDR48	2.77e-05	197	138	8	6960_DN
Drug	Corynanthine hydrochloride [66634-44-4]; Up 200; 10.2uM; MCF7; HT_HG-U133A	NPTX1 ERP44 SEC24A AP4E1 RBFOX1 PLAUR RERE MUC5AC	2.87e-05	198	138	8	4811_UP
Drug	Naftopidil dihydrochloride [57149-08-3]; Up 200; 8.6uM; PC3; HT_HG-U133A	PGPEP1 ARHGEF17 HOXB3 NEO1 PAX8 ZMIZ2 VAV2 BRWD1	2.98e-05	199	138	8	4193_UP
Drug	Coralyne chloride hydrate [38989-38-7]; Up 200; 9.6uM; MCF7; HT_HG-U133A	FLI1 SASH1 THOC5 NFIB RERE PLEC VAV2 CA4	2.98e-05	199	138	8	2652_UP
Drug	Khellin [82-02-0]; Up 200; 15.4uM; PC3; HT_HG-U133A	FLI1 THOC5 SHC2 NFIB R3HDM1 MUC5AC VAV2 COL1A1	2.98e-05	199	138	8	6641_UP
Drug	estradiol, USP; Up 200; 0.01uM; MCF7; HT_HG-U133A	FLI1 APC EGR3 PAX8 RBFOX1 ARC AFDN COL1A1	3.08e-05	200	138	8	5601_UP
Drug	spiromesifen	ACACA BSN	3.65e-05	2	138	2	CID009907412
Drug	1-adamantaneacetic acid	BOC ACACA APC	4.61e-05	12	138	3	CID000123221
Drug	Mal.4	ARHGAP32 PAX8 RERE COL1A1 WDR48	7.68e-05	72	138	5	CID000122821
Drug	Z-15	ACACA CPT1A ABCC8	1.15e-04	16	138	3	CID000477539
Drug	Thr-lys-pro	BOC CPN1 RERE	1.39e-04	17	138	3	CID000170596
Drug	AC1L1G2K	ERBB4 APC PTK2 BSN COL1A1	1.60e-04	84	138	5	CID000003498
Drug	Lidocaone hydrochloride [73-78-9]; Down 200; 14.8uM; MCF7; HT_HG-U133A	FLI1 TCF7 APC ABCC8 RBFOX1 R3HDM1 VAV2	1.63e-04	190	138	7	4421_DN
Drug	GW8510; Up 200; 10uM; MCF7; HT_HG-U133A	TCF7 THOC5 ZMIZ2 PLAUR MUC5AC CA4 COL1A1	1.74e-04	192	138	7	7062_UP
Drug	17-AAG; Down 200; 1uM; MCF7; HT_HG-U133A	C15orf39 KDM6B PCF11 EGR3 TLE3 ZMIZ2 PLEC	1.74e-04	192	138	7	5222_DN
Drug	retinoic acid; Down 200; 1uM; MCF7; HT_HG-U133A_EA	SASH1 APC KDM6B ARHGEF17 EGR3 ZMIZ2 PLAUR	1.74e-04	192	138	7	849_DN
Drug	staurosporine; Up 200; 0.01uM; MCF7; HG-U133A	ACACA PRSS23 EGR3 NFIB SLC25A13 YLPM1 PLAUR	1.79e-04	193	138	7	425_UP
Drug	Carbachol [51-83-2]; Down 200; 21.8uM; MCF7; HT_HG-U133A	TCF7 SNUPN PTK2 GLI3 TLE3 PLAUR WDR48	1.85e-04	194	138	7	5342_DN
Drug	Atovaquone [95233-18-4]; Up 200; 11uM; MCF7; HT_HG-U133A	APC ZC3H3 AFDN BSN MUC5AC CA4 COL1A1	1.85e-04	194	138	7	4786_UP
Drug	Ofloxacin	PTK2 PLAUR VAV2 COL1A1	1.88e-04	47	138	4	ctd:D015242
Drug	Loperamide hydrochloride [34552-83-5]; Down 200; 7.8uM; PC3; HG-U133A	ACACA CPT1A ZC3H3 THOC5 PCF11 UGGT2 COL1A1	1.91e-04	195	138	7	1949_DN
Drug	Talampicillin hydrochloride [39878-70-1]; Up 200; 7.8uM; PC3; HT_HG-U133A	FLI1 ERP44 APC ZMIZ2 NAV3 C7 TMC5	1.91e-04	195	138	7	7254_UP
Drug	Betonicine [515-25-3]; Up 200; 25.2uM; MCF7; HT_HG-U133A	FLI1 ATN1 HOXB3 PAX8 RBFOX1 AFDN SEZ6L	1.91e-04	195	138	7	6063_UP
Drug	Harmaline hydrochloride dihydrate [6027-98-1]; Up 200; 14uM; MCF7; HT_HG-U133A	ATN1 C15orf39 RYR2 NFATC4 PAX8 ARC COL1A1	1.91e-04	195	138	7	2805_UP
Drug	Xamoterol hemifumarate [73210-73-8]; Up 200; 5uM; MCF7; HT_HG-U133A	ERP44 RYR2 PTPRS ZMIZ2 RBFOX1 PLAUR COL1A1	1.91e-04	195	138	7	3401_UP
Drug	Tobramycin [32986-56-4]; Up 200; 8.6uM; MCF7; HT_HG-U133A	NPTX1 ATN1 HOXB3 FZD5 RERE CA4 COL1A1	1.91e-04	195	138	7	4162_UP
Drug	Fenoprofen calcium salt dihydrate [53746-45-5]; Up 200; 7.2uM; MCF7; HT_HG-U133A	ATN1 THOC5 PAX8 ZMIZ2 RBFOX1 AFDN COL1A1	1.91e-04	195	138	7	4736_UP
Drug	Methoxy-6-harmalan [3589-73-9]; Down 200; 18.6uM; HL60; HG-U133A	SFMBT1 FLI1 ASXL1 ERCC6 KDM6B RERE COL1A1	1.91e-04	195	138	7	1743_DN
Drug	9-deoxy-9-methylene-16,16-dimethyl Prostaglandin E2; Up 200; 10uM; PC3; HT_HG-U133A	CPT1A NFIB LYPD3 UGGT2 R3HDM1 MUC5AC BRWD1	1.91e-04	195	138	7	7504_UP
Drug	Piperacetazine [3819-00-9]; Up 200; 9.8uM; PC3; HT_HG-U133A	ATN1 THOC5 RYR2 AP4E1 ZMIZ2 LYPD3 AFDN	1.91e-04	195	138	7	5834_UP
Drug	Nifenazone [2139-47-1]; Up 200; 13uM; PC3; HT_HG-U133A	FLI1 THOC5 NFIB TLE3 C7 TMC5 VAV2	1.97e-04	196	138	7	7314_UP
Drug	Ergocryptine-alpha [511-09-1]; Up 200; 7uM; PC3; HT_HG-U133A	NPTX1 ATN1 APC HOXB3 SHC2 PAX8 CELF3	1.97e-04	196	138	7	3817_UP
Drug	Loperamide hydrochloride [34552-83-5]; Up 200; 7.8uM; HL60; HG-U133A	APC GLI3 YLPM1 UGGT2 PLS1 SEZ6L WDR48	1.97e-04	196	138	7	2033_UP
Drug	CP-320650-01 [172079-28-6]; Down 200; 1uM; PC3; HT_HG-U133A	ATN1 APC PGPEP1 KDM6B PTPRS ZMIZ2 RERE	1.97e-04	196	138	7	4560_DN
Drug	Quinic acid [86-68-0]; Down 200; 19.6uM; HL60; HT_HG-U133A	PGPEP1 CPT1A KDM6B ZC3H3 THOC5 ARHGEF9 PLS1	1.97e-04	196	138	7	2978_DN
Drug	Lovastatin [75330-75-5]; Down 200; 9.8uM; MCF7; HT_HG-U133A	FLI1 NPTX1 C15orf39 ZC3H3 AP4E1 NFIB VAV2	1.97e-04	196	138	7	4978_DN
Drug	Tremorine dihydrochloride [300-68-5]; Up 200; 15uM; MCF7; HT_HG-U133A	APC PGPEP1 ARHGEF17 ARHGEF9 AFDN PLEC COL1A1	1.97e-04	196	138	7	6273_UP
Drug	Prilocaine hydrochloride [1786-81-8]; Down 200; 15.6uM; MCF7; HT_HG-U133A	ERP44 NFIB GLI3 ZMIZ2 RERE MUC5AC COL1A1	1.97e-04	196	138	7	2314_DN
Drug	Methoxy-8-psoralen [298-81-7]; Down 200; 18.6uM; MCF7; HT_HG-U133A	C15orf39 ZC3H3 ZMIZ2 CDK5RAP2 PLAUR SLC52A2 WDR48	1.97e-04	196	138	7	5007_DN
Drug	Epirizole [18694-40-1]; Up 200; 17uM; MCF7; HT_HG-U133A	ATN1 SASH1 ZC3H3 RYR2 NFIB CA4 COL1A1	1.97e-04	196	138	7	1681_UP
Drug	AC1O0B8G	ERBB4 TCF7 FMO3 APC PRSS23 BCAR1 PTK2 RERE	2.02e-04	262	138	8	CID000091605
Drug	Kanamycin A sulfate [25389-94-0]; Up 200; 6.8uM; PC3; HT_HG-U133A	FMO3 THSD7A KDM6B ARHGEF17 RYR2 PAX8 FZD5	2.03e-04	197	138	7	4625_UP
Drug	Nomifensine maleate [32795-47-4]; Up 200; 11.2uM; MCF7; HT_HG-U133A	FLI1 ERP44 AFDN R3HDM1 VAV2 CA4 COL1A1	2.03e-04	197	138	7	7217_UP
Drug	Nadide [53-84-9]; Down 200; 6uM; MCF7; HT_HG-U133A	SASH1 C15orf39 PGPEP1 KDM6B RYR2 TLE3 WDR48	2.03e-04	197	138	7	7227_DN
Drug	Trimipramine maleate salt [521-78-8]; Down 200; 9.8uM; HL60; HT_HG-U133A	CPT1A RYR2 PAX8 PTPRS ZMIZ2 RBFOX1 VAV2	2.03e-04	197	138	7	3004_DN
Drug	Medrysone [2668-66-8]; Up 200; 11.6uM; PC3; HT_HG-U133A	FLI1 ATN1 APC ARHGEF17 PAX8 RBFOX1 RERE	2.03e-04	197	138	7	4266_UP
Drug	Torsemide [56211-40-6]; Up 200; 11.4uM; PC3; HT_HG-U133A	ERP44 THOC5 RYR2 RBFOX1 R3HDM1 MUC5AC COL1A1	2.03e-04	197	138	7	5057_UP
Drug	Piperacillin sodium salt [59703-84-3]; Down 200; 7.4uM; PC3; HT_HG-U133A	FLI1 APC RYR2 PAX8 PTPRS ZMIZ2 RERE	2.03e-04	197	138	7	3763_DN
Drug	Suprofen [40828-46-4]; Down 200; 15.4uM; HL60; HT_HG-U133A	ERP44 CPT1A PAX8 RBFOX1 YLPM1 AFDN PLEC	2.03e-04	197	138	7	3005_DN
Drug	Spiramycin [8025-81-8]; Down 200; 4.8uM; HL60; HT_HG-U133A	TCF7 APC EXT2 THOC5 RYR2 AFDN PLEC	2.03e-04	197	138	7	2558_DN
Drug	Triflupromazine hydrochloride [1098-60-8]; Down 200; 10.2uM; HL60; HT_HG-U133A	TCF7 MANEA PTK2 YJU2B YLPM1 ARHGEF9 RERE	2.03e-04	197	138	7	1855_DN
Drug	Doxazosin mesylate [77883-43-3]; Down 200; 7.4uM; MCF7; HT_HG-U133A	NPTX1 ERCC6 ATN1 APC NFIB PLAUR VAV2	2.03e-04	197	138	7	3363_DN
Drug	Papaverine hydrochloride [61-25-6]; Down 200; 10.6uM; MCF7; HT_HG-U133A	TCF7 PGPEP1 ZC3H3 NFIB GLI3 YLPM1 PLAUR	2.03e-04	197	138	7	2747_DN
Drug	Alfadolone acetate [23930-37-2]; Up 200; 10.2uM; PC3; HT_HG-U133A	NPTX1 PCF11 NFIB ZMIZ2 R3HDM1 TMC5 BRWD1	2.03e-04	197	138	7	7262_UP
Drug	Doxazosin mesylate [77883-43-3]; Up 200; 7.4uM; PC3; HT_HG-U133A	HNF4G THOC5 PAX8 ZMIZ2 CELF3 AFDN RERE	2.03e-04	197	138	7	6642_UP
Drug	SB 203580; Up 200; 1uM; MCF7; HT_HG-U133A	TCF7 NFATC4 PAX8 GLI3 TMC5 MUC5AC CA4	2.03e-04	197	138	7	7061_UP
Drug	Nifuroxazide [965-52-6]; Up 200; 14.6uM; PC3; HT_HG-U133A	NPTX1 AP4E1 HOXB3 ZMIZ2 ARHGEF9 LYPD3 SEZ6L	2.10e-04	198	138	7	4253_UP
Drug	Gossypol [303-45-7]; Down 200; 7.8uM; MCF7; HT_HG-U133A	NPTX1 ATN1 ZC3H3 ZMIZ2 YLPM1 ARC RERE	2.10e-04	198	138	7	4762_DN
Drug	Iobenguane sulfate; Up 200; 10.8uM; MCF7; HT_HG-U133A	ERCC6 ATN1 APC PAX8 ZMIZ2 VAV2 COL1A1	2.10e-04	198	138	7	2878_UP
Drug	Cephapirin sodium salt [24356-60-3]; Down 200; 9uM; HL60; HT_HG-U133A	C15orf39 KDM6B THOC5 ZMIZ2 RERE R3HDM1 TMC5	2.10e-04	198	138	7	2730_DN
Drug	Remoxipride Hydrochloride [73220-03-8]; Up 200; 9.8uM; MCF7; HT_HG-U133A	THSD7A ATN1 APC ITIH5 PAX8 RBFOX1 ARC	2.10e-04	198	138	7	5443_UP
Drug	Isoniazid [54-85-3]; Down 200; 29.2uM; MCF7; HT_HG-U133A	TCF7 NPTX1 ERP44 APC CDK5RAP2 VAV2 CA4	2.10e-04	198	138	7	2246_DN
Drug	Melatonin [73-31-4]; Down 200; 17.2uM; MCF7; HT_HG-U133A	NPTX1 ARHGEF17 ZC3H3 PTPRS PLEC VAV2 WDR48	2.10e-04	198	138	7	5393_DN
Drug	Pantothenic acid calcium salt monohydrate [63409-48-3]; Up 200; 8uM; PC3; HT_HG-U133A	APC PGPEP1 THOC5 RYR2 RBFOX1 VAV2 SEZ6L	2.10e-04	198	138	7	4189_UP
Drug	Ketoprofen [22071-15-4]; Down 200; 15.8uM; MCF7; HT_HG-U133A	TCF7 ATN1 ERP44 PTPRS ZMIZ2 CA4 COL1A1	2.10e-04	198	138	7	2316_DN
Drug	Iopamidol [60166-93-0]; Down 200; 5.2uM; MCF7; HT_HG-U133A	TCF7 ACACA SASH1 PGPEP1 NFIB YLPM1 WDR48	2.10e-04	198	138	7	7189_DN
Drug	Nafcillin sodium salt monohydrate [7177-50-6]; Up 200; 8.8uM; MCF7; HT_HG-U133A	ERP44 APC EGR3 NFIB ZMIZ2 RERE COL1A1	2.10e-04	198	138	7	4103_UP
Drug	Nifenazone [2139-47-1]; Up 200; 13uM; MCF7; HT_HG-U133A	TCF7 ATN1 PAX8 ARC VAV2 SEZ6L COL1A1	2.10e-04	198	138	7	2285_UP
Drug	Mephenesin [59-47-2]; Down 200; 22uM; MCF7; HT_HG-U133A	ERCC6 RYR2 YJU2B PTPRS ZMIZ2 COL1A1 BRWD1	2.10e-04	198	138	7	4698_DN
Drug	Fursultiamine Hydrochloride [2105-43-3]; Up 200; 9.2uM; MCF7; HT_HG-U133A	FOXJ2 PTPRS ZMIZ2 ARHGEF9 ARC TMC5 COL1A1	2.10e-04	198	138	7	7349_UP
Drug	rosiglitazone; Down 200; 10uM; HL60; HT_HG-U133A	ARHGAP32 ERP44 SEC24A APC CPT1A ARHGEF9 AFDN	2.16e-04	199	138	7	2693_DN
Drug	Brinzolamide [138890-62-7]; Up 200; 10.4uM; MCF7; HT_HG-U133A	ARHGEF17 PTPRS ZMIZ2 RBFOX1 VAV2 CA4 COL1A1	2.16e-04	199	138	7	3230_UP
Drug	Hesperetin [520-33-2]; Up 200; 13.2uM; MCF7; HT_HG-U133A	FLI1 ARHGEF17 PTPRS RBFOX1 PLAUR MUC5AC CA4	2.16e-04	199	138	7	1531_UP
Drug	Hemicholinium bromide [312-45-8]; Up 200; 7uM; MCF7; HT_HG-U133A	NPTX1 ARHGEF17 AP4E1 ZMIZ2 AFDN RERE MUC5AC	2.16e-04	199	138	7	3216_UP
Drug	5230742; Down 200; 17uM; MCF7; HT_HG-U133A_EA	ACACA EXT2 ARHGEF17 ZC3H3 EGR3 TLE3 ZMIZ2	2.16e-04	199	138	7	862_DN
Drug	Nitrofural [59-87-0]; Down 200; 20.2uM; MCF7; HT_HG-U133A	TUSC3 APC SNUPN NFIB GLI3 CDK5RAP2 UGGT2	2.16e-04	199	138	7	5321_DN
Drug	Cyclacillin [3485-14-1]; Up 200; 11.8uM; MCF7; HT_HG-U133A	APC RYR2 NFIB GLI1 AFDN VAV2 COL1A1	2.16e-04	199	138	7	3882_UP
Drug	semustine; Down 200; 100uM; MCF7; HT_HG-U133A	ATN1 ARHGEF17 NFIB ARC PLAUR MUC5AC CA4	2.16e-04	199	138	7	7487_DN
Drug	2-propylpentanoic acid; Up 200; 1000uM; MCF7; HT_HG-U133A	NPTX1 PAX8 NFIB ZMIZ2 ARC VAV2 BRWD1	2.16e-04	199	138	7	6929_UP
Drug	Delsoline [509-18-2]; Down 200; 8.6uM; MCF7; HT_HG-U133A	FLI1 SASH1 PGPEP1 CPT1A NFIB PLAUR CA4	2.16e-04	199	138	7	6075_DN
Drug	Oxone	BOC PGPEP1	2.17e-04	4	138	2	CID000160937
Drug	allylsilane	BOC ACACA	2.17e-04	4	138	2	CID000140349
Drug	Tolfenamic acid [13710-19-5]; Up 200; 15.2uM; MCF7; HT_HG-U133A	CDHR1 PGPEP1 ARC RERE C7 R3HDM1 VAV2	2.23e-04	200	138	7	5454_UP
Drug	Cefsulodin sodium salt [52152-93-9]; Up 200; 7.2uM; MCF7; HT_HG-U133A	NFATC4 PAX8 PTPRS RBFOX1 AFDN RERE MUC5AC	2.23e-04	200	138	7	3328_UP
Drug	Folinic acid calcium salt [6035-45-6]; Down 200; 7.8uM; MCF7; HT_HG-U133A	NPTX1 ERCC6 PGPEP1 AP4E1 TLE3 PLAUR TMC5	2.23e-04	200	138	7	3442_DN
Disease	neuroticism measurement, cognitive function measurement	ASXL1 ERBB4 NPTX1 THSD7A ANKS1B APC HNF4G FAM193A ZMIZ2 RBFOX1 YLPM1 RERE	1.20e-05	566	135	12	EFO_0007660, EFO_0008354
Disease	dentatorubral-pallidoluysian atrophy (implicated_via_orthology)	ATN1 RERE	2.08e-05	2	135	2	DOID:0060162 (implicated_via_orthology)
Disease	QRS-T angle	ERBB4 ZFPM1 RYR2 RBFOX1 VAV2	1.30e-04	106	135	5	EFO_0020097
Disease	kallikrein‐6 measurement	C7 LILRB5	3.08e-04	6	135	2	EFO_0010622
Disease	unipolar depression, mood disorder	ERBB4 THSD7A RBFOX1 YLPM1 RERE	3.87e-04	134	135	5	EFO_0003761, EFO_0004247
Disease	neuroimaging measurement	COL26A1 APC PGPEP1 PTK2 ITIH5 NEO1 NFIB GLI3 PKD1 NAV3 RERE PLEC TMC5 ZSWIM4	4.02e-04	1069	135	14	EFO_0004346
Disease	cataract	THSD7A PKD1L1 CPT1A EGR3 RBFOX1	4.89e-04	141	135	5	MONDO_0005129
Disease	household income	ERBB4 SGIP1 THSD7A KMT2E NFIB ZMIZ2 BSN	5.17e-04	304	135	7	EFO_0009695
Disease	neutrophil count	FOXJ2 SGIP1 KDM6B KMT2E VWA7 ADAR AP4E1 RBFOX1 PKD1 STARD3 SPSB4 PLAUR RERE R3HDM1 DNMT1 PEAR1	5.96e-04	1382	135	16	EFO_0004833
Disease	response to anticonvulsant	THSD7A SASH1 NAV3 FOXI2	6.37e-04	85	135	4	GO_0036277
Disease	eosinophil percentage of leukocytes	FLI1 TCF7 ZFPM1 KDM6B EOMES FAM193A NFATC2 TLE3 PLAUR RERE MUC5AC	6.58e-04	746	135	11	EFO_0007991
Disease	primary bacterial infectious disease (implicated_via_orthology)	GLI1 GLI3	7.32e-04	9	135	2	DOID:0050338 (implicated_via_orthology)
Disease	prostate cancer (is_marker_for)	ERBB4 TCF7 KMT2E PTK2 DNMT1	7.73e-04	156	135	5	DOID:10283 (is_marker_for)
Disease	Tinnitus, wellbeing measurement	PTK2 NFATC2 RBFOX1 FOXI2	1.01e-03	96	135	4	EFO_0007869, HP_0000360
Disease	Childhood Medulloblastoma	FLI1 APC DNMT1	1.01e-03	43	135	3	C0278510
Disease	Melanotic medulloblastoma	FLI1 APC DNMT1	1.01e-03	43	135	3	C1275668
Disease	Medullomyoblastoma	FLI1 APC DNMT1	1.01e-03	43	135	3	C0205833
Disease	Desmoplastic Medulloblastoma	FLI1 APC DNMT1	1.01e-03	43	135	3	C0751291
Disease	Adult Medulloblastoma	FLI1 APC DNMT1	1.01e-03	43	135	3	C0278876
Disease	gastroesophageal reflux disease	ERBB4 PGPEP1 YLPM1 NAV3	1.21e-03	101	135	4	EFO_0003948
Disease	Gastrointestinal Stromal Sarcoma	BOC GLI1 GLI3	1.31e-03	47	135	3	C3179349
Disease	dickkopf‐related protein 1 measurement	ZFPM1 PEAR1	1.33e-03	12	135	2	EFO_0010620
Disease	rotator cuff tear	THSD7A SASH1	1.33e-03	12	135	2	EFO_1001250
Disease	Malignant neoplasm of breast	BOC ERBB4 ERCC6 MANEA DTX3L BCAR1 CPT1A ADAR THOC5 EOMES GLI1 TLE3 DNMT1	1.33e-03	1074	135	13	C0006142
Disease	Colorectal Carcinoma	BOC ERCC6 ACACA APC DSCAML1 CDKL5 PAX8 PTPRS GLI3 ABCC8	1.50e-03	702	135	10	C0009402
Disease	ximenoylcarnitine (C26:1) measurement	GALP CPT1A	1.57e-03	13	135	2	EFO_0800543
Disease	cerotoylcarnitine (C26) measurement	GALP CPT1A	1.57e-03	13	135	2	EFO_0800542
Disease	gallbladder cancer (is_implicated_in)	APC GLI1	1.57e-03	13	135	2	DOID:3121 (is_implicated_in)
Disease	Medulloblastoma	FLI1 APC DNMT1	1.57e-03	50	135	3	C0025149
Disease	Gastrointestinal Stromal Tumors	BOC GLI1 GLI3	1.57e-03	50	135	3	C0238198
Disease	S-6-hydroxywarfarin measurement	WIPF3 SOX8 LIPK ZC3H3 THOC5 TIAM2 VAV2	1.57e-03	368	135	7	EFO_0803326
Disease	glucose metabolism measurement, age-related hearing impairment	THSD7A NFATC2 NAV3	1.76e-03	52	135	3	EFO_0005782, EFO_0009367
Disease	interleukin-6 measurement	ANKS1B KMT2E ADAR RASEF	1.78e-03	112	135	4	EFO_0004810
Disease	cortical thickness	COL26A1 PGPEP1 HNF4G ITIH5 NEO1 GLI3 YLPM1 PKD1 NAV3 CDK5RAP2 RERE PLEC ZSWIM4	1.83e-03	1113	135	13	EFO_0004840
Disease	Myopia	FLI1 CDHR1 ANKS1B DSCAML1 PTK2 RYR2 RBFOX1	2.02e-03	385	135	7	HP_0000545
Disease	digit length ratio	FLI1 GLI3	2.39e-03	16	135	2	EFO_0004841
Disease	Polyposis, Adenomatous Intestinal	FMO3 APC	2.39e-03	16	135	2	C2713442
Disease	Familial Intestinal Polyposis	FMO3 APC	2.39e-03	16	135	2	C2713443
Disease	idiopathic dilated cardiomyopathy	BOC THSD7A SASH1	2.65e-03	60	135	3	EFO_0009094
Disease	basophil measurement	FLI1 ZFPM1 RERE	2.65e-03	60	135	3	EFO_0803539
Disease	pre-malignant neoplasm (biomarker_via_orthology)	GLI1 GLI3	2.70e-03	17	135	2	DOID:0060071 (biomarker_via_orthology)
Disease	Adenomatous Polyposis Coli	FMO3 APC	2.70e-03	17	135	2	C0032580
Disease	sinusitis (is_marker_for)	CHIA PLAUR	3.03e-03	18	135	2	DOID:0050127 (is_marker_for)
Disease	allergic rhinitis	BOC NFATC2 RBFOX1 RERE	3.31e-03	133	135	4	EFO_0005854
Disease	coronary artery disease	ERBB4 THSD7A DOK3 PGPEP1 ZFPM1 BCAR1 AP4E1 FNDC1 NFIB PRIM2 RBFOX1 BSN SEZ6L	3.34e-03	1194	135	13	EFO_0001645
Disease	superior temporal gyrus volume measurement	ITIH5 EGR3	3.38e-03	19	135	2	EFO_0010331
Disease	polymyositis	SDK2 THSD7A	3.74e-03	20	135	2	EFO_0003063
Disease	susceptibility to hepatitis A infection measurement	SHC2 RBFOX1 COL1A1	3.78e-03	68	135	3	EFO_0008415
Disease	age-related hearing impairment	SASH1 SNX33 CPN1 PTK2 GLI3 RBFOX1	3.85e-03	324	135	6	EFO_0005782
Disease	brain measurement, neuroimaging measurement	COL26A1 DSCAML1 PTK2 ITIH5 NEO1 NAV3 PLEC ZSWIM4	3.90e-03	550	135	8	EFO_0004346, EFO_0004464
Disease	cigarettes per day measurement	SFMBT1 ASXL1 THSD7A ZFPM1 HNF4G ZMIZ2 STARD3	4.12e-03	438	135	7	EFO_0006525

Protein segments in the cluster

Peptide	Gene	Start	Entry
GLFKLQGKDSYPHPP	nan	76	A4D1N5
QGKDSYPHPPTVLLG	nan	81	A4D1N5
PAPKLALPGHAESYN	BOP1	301	Q14137
VANQPPSPGGKSAYA	AFDN	1176	P55196
PEYHNASNGPPKAED	ERBB4	1186	Q15303
SLFPYQAAAGAPHGP	EOMES	161	O95936
GQPAPDALYPNGVHP	CELF3	291	Q5SZQ8
LSKNGRYQPSIPPHA	DISP3	226	Q9P2K9
LNNHPPTFYGESGPQ	CDHR1	346	Q96JP9
AQPGKGPCLSYHPGN	CREB3L3	116	Q68CJ9
FEDPPNHARSPGNKG	DNMT1	1096	P26358
SKAQQGLYQVPGPSP	BCAR1	121	P56945
LHAYPGPRGGQVAKP	ARC	11	Q7LC44
PPYGRLLANSNAHPG	ATN1	446	P54259
YPGSRGSPPQDKHLF	CHIA	141	Q9BZP6
DGHCKGDINPNIPYP	CPT1A	501	P50416
MADHYVPVPGGPNNN	ACACA	171	Q13085
YGADANIPKNSGHLP	ASB14	271	A6NK59
STYGLPAGGIQPHPQ	CD2AP	86	Q9Y5K6
KAPSGLQGPPQAHQF	FAM193A	16	P78312
LLPPYPLNGEHTQAG	ASXL1	696	Q8IXJ9
PQDPLNHGQYLVPDG	ARHGEF9	471	O43307
EGLSQGAAPYKPPHQ	AP4E1	631	Q9UPM8
PPVGAAYQDSPGEQK	CDK5RAP2	1011	Q96SN8
GYPASGHPVSQPVLQ	R3HDM1	616	Q15032
SHNDPAKNPPGYLED	NFIB	196	O00712
SPSHTKGEQGLYPLP	PAX8	251	Q06710
SPKFIGHSPQPLGYD	RASEF	386	Q8IZ41
GSGENLAPYHPIKPQ	NPTX1	336	Q15818
EGPPQLPGAQSPAYH	ARHGEF17	256	Q96PE2
PPKEYDPGQFAGLLH	ANKS1B	596	Q7Z6G8
YLETHGHPPEPGQKG	ERCC6	991	P0DP91
PNAHKVASPPSGPAY	NFATC2	46	Q13469
VYPNLPKESFPGLNH	FMO3	151	P31513
NPYGGPEHLMLHNSP	GLI3	1221	P10071
GAPAPPNGHKKQRTY	ITIH5	726	Q86UX2
LYGKPQLDDVSQPPG	RPS6KC1	306	Q96S38
NPGIPGADHYQTPAL	KDM6B	416	O15054
GPDLVQYQPQHGPGL	BSN	2121	Q9UPA5
QYQPQHGPGLSAPQS	BSN	2126	Q9UPA5
EGHPSPGNLAQYGPA	BSN	2156	Q9UPA5
GQAQATAHPPGYEPG	FOXI2	16	Q6ZQN5
YLVPSDHPKGNFVPQ	PDCD7	451	Q8N8D1
SHVNKPPYPALGGNM	PLS1	441	Q14651
FVHVPPLGKPYNADQ	PGPEP1	166	Q9NXJ5
GLPPGHYDSPKNSHI	PEAR1	1001	Q5VY43
AAIQGALNGPDHPPK	NAV3	1646	Q8IVL0
SKGTPAPLPNGNHRY	ZFPM1	961	Q8IX07
AMYCNGNKGPEHPNP	PMS2P11	41	Q13670
QHGYLSPKPPSQQLG	KMT2E	1461	Q8IZD2
KRASGPPGNEHLYEN	DOK3	386	Q7L591
GCYKDHGNPPPLTGT	KREMEN1	121	Q96MU8
NTYGPGFGPNLPNHK	GLI1	946	P08151
GFGPNLPNHKSGSYP	GLI1	951	P08151
AHFYRPAGAAGPEPK	LILRB5	491	O75023
PSPGPHGGDKETYNN	MUC5AC	2131	P98088
FPSPGPHGGDKETYN	MUC5AC	3236	P98088
SPGPHGGDKETYNNI	MUC5AC	3536	P98088
FPSPGPHGGDKETYN	MUC5AC	4641	P98088
GPPDPLHGNSLYQKV	TEPSIN	106	Q96N21
AEGPPPLYNTNHDFK	FOXJ2	226	Q9P0K8
SKNGPPYPQGAGQLD	ARHGAP32	1891	A7KAX9
PSPPQGSGQEQYKIA	HNF4G	376	Q14541
AKNYPQGRHNPPDDI	MANEA	136	Q5SRI9
QYPAKGGPQQPHNKG	LYPD3	311	O95274
HKGPGLQHVGLYTPN	HPDL	251	Q96IR7
LPPTFHPGDQKQYGG	PTPRS	1216	Q13332
PSGALPKAYPDNHLS	PCF11	1251	O94913
ILSNPPSQGDYHGCP	PRIM2	371	P49643
CPGHDTGQPRAKPEY	FZD5	486	Q13467
RTGPPGPAATYHKQV	FZD5	566	Q13467
AIDGLPYSHPPQPSK	GALP	71	Q9UBC7
PSAAVGYPGMKPQQH	BOC	941	Q9BWV1
PDGYEVAAAQGPNKP	CPN1	131	P15169
SGGGLPAPYQAKQLH	CA4	101	P22748
RLKPPVHYNGPSKAG	ADAR	431	P55265
EEHPNPGKRYPGIQR	DTX3L	646	Q8TDB6
AKGSGNPQQYHPVPL	DSCAML1	726	Q8TD84
RQLSDPNHGSPPGLY	FAM83C	396	Q9BQN1
QAQNPHGYGPISPSV	FNDC1	1731	Q4ZHG4
HDPQGNPGLAYSPQD	EGR3	161	Q06889
DKPPPNIELTGNGYN	C7	131	P10643
ASGSPDYGQPHKINP	FLI1	36	Q01543
PLPYGSHNIALGQLP	FASTKD1	741	Q53R41
YESPSPPAFGKAHQN	HOXB3	286	P14651
PPAFGKAHQNAYALP	HOXB3	291	P14651
TQDQLKENGYPFPHP	REXO1L1P	376	Q8IX06
DGNPHPTKYQRLVPG	BRWD1	596	Q9NSI6
GDNIIYKPPGHSAPD	ERP44	206	Q9BS26
YSEQLGAKSGPNGHP	CDKL5	926	O76039
PPPLDSQNGDIQGYK	SDK2	1646	Q58EX2
ESKGGGNHPLLVPYD	RYR2	2861	Q92736
LFKKNPYPGSQAPGQ	PKD1L1	1516	Q8TDX9
ALQQHGYPEPGAGSP	COL26A1	31	Q96A83
PAGPPAQYSVTLHGQ	PKD1	691	P98161
YHLPSILQAGDGPPQ	ARHGAP30	251	Q7Z6I6
GGQPSSGLQDPPHLY	FOXN4	126	Q96NZ1
KPQSGHYDPEEGPKH	MEIOC	611	A2RUB1
APPQNGIPAEYTAPH	RBFOX1	31	Q9NWB1
PHILGQYLGNSGPQK	SEZ6L	691	Q9BYH1
PYNGGRPCPKLDHVN	THSD7A	1066	Q9UPZ6
PLGHIDFYPNGGNKQ	LIPI	221	Q6XZB0
DVHPLPAEGYNKVGP	NFATC4	831	Q14934
NFQLPGSYPHPIPAK	SEC24A	51	O95486
GNQHIYQPVGKPDPA	PTK2	856	Q05397
GPQCHKGTPLPTYEE	PRSS23	66	O95084
PPAPATQNGQITGYK	NEO1	656	Q92859
QAAGTTPGPDPKAYQ	SLC52A2	256	Q9HAB3
GTNGHPPLNLSYPGA	SNX33	136	Q8WV41
GYPGLKAEPASPAQD	WIPF3	271	A6NGB9
GQAPLGTSPAAAYPH	RERE	881	Q9P2R6
PHIKTEQPSPGHYGD	SOX8	336	P57073
PAGPLTTKPDYAGHQ	SNUPN	291	O95149
AKPPTHKYVRGENGP	STARD3	371	Q14849
PHEPTPQGPASKYQA	ABCC8	626	Q09428
QGEPSKPQASGYAPK	APC	1996	P25054
RINLPAPNPDHVGGY	SLC25A13	626	Q9UJS0
HPEKQGSYSPALPLQ	C15orf39	291	Q6ZRI6
LPQPPQEKAHDGGRY	COL1A1	1201	P02452
HKPPVNGSYFAHVNP	C11orf54	121	Q9H0W9
IRGPPYAHKNPHNGQ	TUSC3	251	Q13454
PQQQPGSEGPSYAKK	TIMM50	51	Q3ZCQ8
YKTLHGNAPAPGTPA	ZC3H3	21	Q8IXZ2
QYRSGAAPQPGPAHL	PLAUR	301	Q03405
QKGNGYFQVPPHTPV	WDR48	501	Q8TAF3
PGKYPHPGLADFADN	TIAM2	1546	Q8IVF5
HNYYNSIPGKEPPLG	SHC2	336	P98077
HDGKNQPGVAYPAFL	SPSB4	151	Q96A44
DGIQPSPHEPPYNSK	SGIP1	31	Q9BQI5
HLLFNMLPGGPPDYN	EXT2	186	Q93063
SPPHPQASPKYLGDA	ZNF395	231	Q9H8N7
HTGEKPYENPNPNAS	ZNF627	441	Q7L945
NYDAQPPGAKHGLAR	SASH1	931	O94885
AVQAGQLKVPPGYHP	PLEC	486	Q15149
YPPDFNPEKHGSLNR	YJU2B	11	P13994
NLLMHYPPPSGAGQH	TCF7	126	P36402
PGAYAGLHNIPPQMS	TLE3	386	Q04726
SKPPPVQQTVDYGHG	YLPM1	1631	P49750
SVPGPTGLHYKPTEQ	ZMIZ2	321	Q8NF64
LDQQYAVGHPPSPGK	SLC46A2	261	Q9BY10
NGLHISPPPGYPSQD	SFMBT1	341	Q9UHJ3
SLGKPDYPGADIQPN	TMC5	201	Q6UXY8
NYHGNPAPPGKPVLT	VAV2	596	P52735
GPLPQALYNGEPFKH	UGGT2	616	Q9NYU1
PGDHGKKTPNPANQY	THOC5	406	Q13769
HPGLYPLTQPVAGLQ	VWA7	616	Q9Y334
GYPFLKPAGISHPEQ	ZNF662	51	Q6ZS27
RKVAYQHVPVPGSPG	ZSWIM4	446	Q9H7M6
PGRTAPKPAVYLQHG	LIPK	71	Q5VXJ0